User Image Cart Icon 0 Search Image

Naringenin

  1. … -current chromatography system with Cu (II)-chiral ionic liquid complexes and hydroxypropyl-β-cyclodextrin as dual chiral selectors for enantioseparation of Naringenin
  2. … , the flavonoid Naringenin, in the cytoplasmic membrane of Rhizobium leguminosarum biovar viciae is caused by the pH-dependent hydrophobicity of Naringenin.
  3. … 3, 6, 8-and 8, 6-di-C-β-d-(glucopyranosyl-xylopyranosyl)-4′, 5, 7-trihydroxyflavones using two direct C-glycosylations of Naringenin and phloroacetophenone with …
  4. … AND EVALUATION OF ANTIBACTERIAL ACTIVITY OF A FLAVANONE DERIVATIVE 8-HYDROXYL Naringenin FROM ELEPHANTOPUS SCABER LINN
  5. … and fatty acids biosynthesis-related genes in Escherichia coli and Staphylococcus aureus: Implications for the antibacterial mechanism of Naringenin
  6. … Biosynthesis, Contributes to the Resistance of Rice to Blast Fungus. The authors regret that in Figure 7I, the chemical structure of Naringenin was shown incorrectly …
  7. … Carbon Dioxide of (2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-ol (Farnesol) and (2S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one (Naringenin)
  8. … effect of Fusarium inoculation and fungicide application on concentrations of flavonoids (apigenin, kaempferol, luteolin, Naringenin, quercetin, rutin, vitexin) in …
  9. … extraction and high performance liquid chromatographic determination of seven flavonoids in citrus fruit juice and human fluid samples: hesperetin and Naringenin as …
  10. … flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, Naringenin, and pelargonidin inhibit …
  11. … grown of 3D-nickel oxide nano flowers on TiO2 nanowire arrays by hydrothermal route for electrochemical determination of Naringenin flavonoid in vegetable …
  12. … in Enzyme Activities of Erythrocyte Glucose 6‐Phosphate Dehydrogenase and 6‐Phosphogluconate Dehydrogenase in Rats Given Naringenin and Lead Acetate
  13. … in healthy humans is markedly enhanced by micellar solubilisation but not further improved by simultaneous ingestion of sesamin, ferulic acid, Naringenin …
  14. … in which the 2, 3 double bond of the chromene ring has been reduced. Such compounds include the flavanones (2, 3-dihydroflavones such as Naringenin or 2, 3 …
  15. … of a new, sensitive, and robust analytical and bio-analytical RP-HPLC method for in-vitro and in-vivo quantification of Naringenin in polymeric nanocarriers
  16. … of a Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Naringin and Its Metabolite, Naringenin, in Human Plasma
  17. … of pea (Pisum sativum L.) by Rhizobium leguminosarum bv. viceae preincubated with Naringenin and hesperetin or application of Naringenin and hesperetin directly …
  18. … of peels of Citrus auriantum, Citrus maxima and Citrus sinensis using different solvents and HPLC-analysis of flavonones-Naringin and Naringenin in peels of …
  19. … polymerase-γ hypothesis in nucleoside reverse transcriptase-induced mitochondrial toxicity revisited: A potentially protective role for citrus fruit-derived Naringenin?
  20. … Tail Dynamics: Structural and Molecular Perspectives into the Therapeutic Activities of Novel CRMP‐2 Inhibitors, Naringenin and Naringenin‐7‐O‐glucuronide, in the …
  21. … UHPLC-ESI (-)-HRMS Methodology for the Simultaneous Quantitative Determination of Hesperidin, Hesperetin, Naringin, and Naringenin in Chicken Plasma
  22. (+/−)‐Naringenin as large conductance Ca2+‐activated K+ (BKCa) channel opener in vascular smooth muscle cells
  23. (2S)-Naringenin from Typha angustata inhibits vascular smooth muscle cell proliferation via a G0/G1 arrest
  24. 17β-Estradiol but not the phytoestrogen Naringenin attenuates aortic cholesterol accumulation in WHHL rabbits
  25. 42PDual inhibitory effects of novel Naringenin analogue in tobacco-carcinogen induced lung cancer via inhibition of PI3K/Akt/mTOR pathway
  26. 5, 7-Dihydroxy-2-(4-hydroxyphenyl) chroman-4-one (Naringenin): X-ray diffraction structures of the Naringenin enantiomers and DFT evaluation of the preferred …
  27. 6-C-(E-Phenylethenyl) Naringenin Attenuates the Stemness of Hepatocellular Carcinoma Cells by Suppressing Wnt/β-Catenin Signaling
  28. 6-C-(E-phenylethenyl) Naringenin induces cell growth inhibition and cytoprotective autophagy in colon cancer cells
  29. 6-C-(E-phenylethenyl)-Naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1
  30. 69 THE EFFECT OF Naringenin (GRAPEFRUIT JUICE) AND ANTIARRHYTHMIC DRUGS ON IKr INHIBITION.
  31. A bioactive Naringenin coumaroyl glucoside from Mabea fistulifera subsp. robusta
  32. A chromatographic-fluorometric method for determination of naringin, Naringenin rutinoside, and related flavanone glycosides in grapefruit juice and juice sacs
  33. A co‐drug conjugate of Naringenin and lipoic acid mediates neuroprotection in a rat model of oxidative stress
  34. A comparison of the chemical reactivity of Naringenin calculated with the M06 family of density functionals
  35. A cytochrome P450 mediated Naringenin 3′-hydroxylase from sweet orange [Citrus sinensis] cell cultures
  36. A cytochrome P450 mediated Naringenin 3′-hydroxylase from sweet orange cell cultures
  37. A facile one-pot hydrothermal synthesis of tin sulfide-decorated reduced graphene oxide nanoribbons and its sensing application for a flavanone Naringenin
  38. A genetic and metabolic analysis revealed that cotton fiber cell development was retarded by flavonoid Naringenin
  39. A high-pressure liquid chromatographic method for the resolution and quantitation of naringin and Naringenin rutinoside in grapefruit juice
  40. A MEKC method for Naringenin from natural and biological samples
  41. A method for measuring Naringenin in biological fluids and its disposition from grapefruit juice by man
  42. A Naringenin–tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells
  43. A naturally occurring Naringenin derivative exerts potent bone anabolic effects by mimicking oestrogen action on osteoblasts
  44. A NodD‐like protein activates transcription of genes involved with Naringenin degradation in a flavonoid‐dependent manner in Herbaspirillum seropedicae
  45. A novel pH-responsive hydrogel based on carboxymethyl cellulose/2-hydroxyethyl acrylate for transdermal delivery of Naringenin
  46. A novel regulatory mechanism of Naringenin through inhibition of T lymphocyte function in contact hypersensitivity suppression
  47. A novel synthesis of Naringenin and related flavanones
  48. A perspective on the modulation of plant and animal two pore channels (TPCs) by the flavonoid Naringenin
  49. A potential role for Naringenin in reversing tamoxifen resistance in MCF-7 breast cancer cells
  50. A rapid method for the determination of naringin, prunin, and Naringenin applied to the assay of naringinase
  51. A recent review of citrus flavanone Naringenin on metabolic diseases and its potential sources for high yield-production
  52. A Review of the Effects of Citrus paradisi (Grapefruit) and Its Flavonoids, Naringin, and Naringenin in Metabolic Syndrome
  53. A review on pharmacological and analytical aspects of Naringenin
  54. A single-molecule study of the inhibition effect of Naringenin on transforming growth factor-β ligand–receptor binding
  55. A stereospecific HPLC method and its application in determination of pharmacokinetics profile of two enantiomers of Naringenin in rats
  56. A Synthetic Naringenin Derivative, 5-Hydroxy-7,4′-diacetyloxyflavanone-N-phenyl Hydrazone (N101-43), Induces Apoptosis through Up-regulation of Fas/FasL …
  57. A validated solid-phase extraction HPLC method for the simultaneous determination of the citrus flavanone aglycones hesperetin and Naringenin in urine
  58. Abatement by Naringenin of doxorubicin-induced cardiac toxicity in rats
  59. Ability of Naringenin, a bioflavonoid, to activate M-type potassium current in motor neuron-like cells and to increase BKCa-channel activity in HEK293T cells transfected …
  60. Absorption and disposition of Naringenin and quercetin after simultaneous administration via intestinal perfusion in mice
  61. Accumulation of dietary Naringenin and metabolites in mice
  62. Across the blood-brain barrier: Neurotherapeutic screening and characterization of Naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer’s disease …
  63. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of Naringenin on diabetic nephropathy
  64. Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis in rats fed Naringenin
  65. Additive antibacterial activity of Naringenin and antibiotic combinations against multidrug resistant Staphylococcus aureus
  66. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of Naringenin in diabetic animals—An in vitro and in vivo approach
  67. Aluminum–induced oxidative stress and hepato-renal impairment in male albino rats: possible protective trial with Naringenin
  68. Amelioration of benzo [a] pyrene-induced oxidative stress and pulmonary toxicity by Naringenin in Wistar rats: a plausible role of COX-2 and NF-κB
  69. Amelioration of experimental streptozotocin-nicotinamide induced diabetes mellitus in wistar rats by the bioflavonoid Naringenin
  70. AMELIORATIVE EFFECT OF Naringenin AGAINST ANTITUBERCULOSIS DRUGS INDUCED ALTERATIONS IN HEMATOLOGICAL PARAMETERS OF …
  71. Ameliorative effect of Naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin-nicotinamide-induced …
  72. An anomalous racemate of Naringenin at 120 K
  73. An Eco‐Friendly Enantioselective Access to (R)‐Naringenin as Inhibitor of Proinflammatory Cytokine Release
  74. An efficient synthesis of the potent phytoestrogens 8-prenylNaringenin and 6-(1, 1-dimethylallyl) Naringenin by europium (III)-catalyzed Claisen rearrangement
  75. An efficient way from Naringenin to carthamidine and isocarthamidine by Aspergillus niger
  76. AN IN SILICO STUDY OF Naringenin-MEDIATED NEUROPROTECTION IN PARKINSON’S
  77. An in vitro and in vivo study of antitumor effects of Naringenin on gastric cancer model.
  78. Analgesic effects of Naringenin in rats with spinal nerve ligation‑induced neuropathic pain
  79. Analysis of Temporal Changes in Growth and Gene Expression for Commensal Gut Microbes in Response to the Polyphenol Naringenin
  80. Analysis of three flavonoids by CE‐uV and CE‐ESI‐MS. Determination of Naringenin from a phytomedicine
  81. Anomalous dissolution property enhancement of Naringenin from spray-dried particles with α-glucosylhesperidin
  82. Antagonistic interactions between the flavonoids hesperetin and Naringenin and β-lactam antibiotics against Staphylococcus aureus
  83. Anti-allergic activity of Naringenin chalcone from a tomato skin extract
  84. Anti-atherogenic effect of citrus flavonoids, naringin and Naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits
  85. Anti-cancer effect of Naringenin chalcone is mediated via the induction of autophagy, apoptosis and activation of PI3K/Akt signalling pathway
  86. Anti-inflammatory activity of naringin and the biosynthesised Naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in …
  87. Anti-inflammatory and anti-arthritic properties of Naringenin via attenuation of NF-κB and activation of the heme oxygenase (HO)-1/related factor 2 pathway
  88. Anti-inflammatory and antifibrotic effects of Naringenin in diabetic mice
  89. Anti-inflammatory role of Naringenin in rats with ethanol induced liver injury
  90. Anti-proliferative effect of Naringenin through p38-dependent downregulation of cyclin D1 in human colorectal cancer cells
  91. Anti-Sindbis activity of flavanones hesperetin and Naringenin
  92. Anti‐Diabetic, Anti‐Inflammatory, and Anti‐Oxidant Effects of Naringenin in an In Vitro Human Model and an In Vivo Murine Model of Gestational Diabetes Mellitus
  93. Antiandrogenic activity of the phytoestrogens Naringenin, 6-(1, 1-dimethylallyl) Naringenin and 8-prenylNaringenin
  94. Antiatherogenic properties of Naringenin, a citrus flavonoid
  95. Antibacterial activity of a novel flavonoid, 7-O-butyl Naringenin, against methicillin-resistant Staphylococcus aureus (MRSA)
  96. Antibacterial activity of Naringenin-rich fraction of pigeon pea leaves toward Salmonella thypi
  97. Anticoccidial efficacy of Naringenin and a grapefruit peel extract in growing lambs naturally-infected with Eimeria spp
  98. Anticoccidial efficacy of Naringenin and a grapefruit peel extract in growing lambs naturally-infected with Eimeria spp.
  99. Antidepressant and Neuroprotective Effects of Naringenin via Sonic Hedgehog-GLI1 Cell Signaling Pathway in a Rat Model of Chronic Unpredictable Mild Stress
  100. Antidepressant-like behavioral, neurochemical and neuroendocrine effects of Naringenin in the mouse repeated tail suspension test
  101. Antidiabetic and toxicological evaluations of Naringenin in normoglycaemic and NIDDM rat models and its implications on extra‐pancreatic glucose regulation
  102. Antidiabetic properties of Naringenin: A citrus fruit polyphenol
  103. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol
  104. Antidiabetic‐Like Effects of Naringenin‐7‐O‐glucoside from Edible Chrysanthemum ‘Kotobuki’ and Naringenin by Activation of the PI3K/Akt Pathway and PPARγ
  105. Antigenotoxic and antioxidant potentials of newly derivatized compound Naringenin-oxime relative to Naringenin on human mononuclear cells
  106. ANTIHYPERGLYCEMIC AND ANTIHYPERLIPIDEMIC EFFECT OF CHRONIC ADMINISTRATION OF Naringenin IN DIABETIC RATS
  107. Antihyperglycemic and antioxidant effects of a flavanone, Naringenin, in streptozotocin–nicotinamide-induced experimental diabetic rats
  108. Antileukemic and therapeutic effects of Naringenin the active principle of Citrus limetta and Citrus sinensis
  109. Antimicrobial Activity of Elfvingia applanata Extract Alone and in Combination with Naringenin
  110. Antimicrobial and Wound Healing Potential of Dietary Flavonoid Naringenin
  111. Antimicrobial effects of Naringenin alone and in combination with related flavonoids
  112. Antimicrobial effects of natural flavonoids and a novel flavonoid, 7-O-Butyl Naringenin, on growth of meat-borne Staphylococcus aureus strains
  113. Antinociceptive and anti-inflammatory effect of Naringenin in different nociceptive and inflammatory mice models
  114. Antinociceptive and anti-inflammatory effects of the citrus flavanone Naringenin
  115. Antiosteoporotic effects of Naringenin on ovariectomy-induced osteoporosis in rat
  116. Antioxidant activity and kinetics studies of quercetin, epicatechin and Naringenin in bulk methyl linoleate
  117. Antioxidant activity of Naringenin on various oxidants induced damages in ARPE-19 cells and HUVEC
  118. Antioxidant and anti apoptotic effects of Naringenin in diabetic mice
  119. Antioxidant and antihyperglycaemic effects of Naringenin arrest the progression of diabetic nephropathy in diabetic rats
  120. Antioxidant and hepatoprotective effects of Naringenin and its β-cyclodextrin formulation in mice intoxicated with carbon tetrachloride: a comparative study
  121. Antioxidant Change in Biosynthesis from Naringenin Chalcone to Flavonoid Apingenin
  122. Antioxidant effects of quercetin and Naringenin are associated with impaired neutrophil microbicidal activity
  123. Antioxidant potential and DPPH radical scavenging kinetics of water-insoluble flavonoid Naringenin in aqueous solution of micelles
  124. Antioxidant Potential of Naringenin Helps to Protect Liver Tissue from Streptozotocin-Induced Damage
  125. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid Naringenin and its glycoside naringin: a comparative study
  126. Antioxidant studies of chitosan nanoparticles containing Naringenin and their cytotoxicity effects in lung cancer cells
  127. Antioxidative effect of flavonoid Naringenin in the lenses of type 1 diabetic rats
  128. Antioxidative Effect of Naringenin on the Activity of Superoxide Dismutase and Glutathione Peroxidase in HepG2 Cells under Hyperglycaemic Conditions.
  129. Antiplatelet aggregation of Naringenin via cyclic nucleotide signaling: in vitro studies
  130. Antiplatelet aggregation of Naringenin via inhibiting PI3K/Akt signaling in vitro
  131. Apigenin and Naringenin ameliorate PKCβII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high …
  132. Apigenin and Naringenin decrease cell number in a dose dependent manner in non-transformed young adult mouse colonocytes (YAMC) but not in those expressing …
  133. Apigenin and Naringenin favorably modulate aberrant crypt foci development and colonic cell cytokinetics
  134. Apigenin and Naringenin Increase Apoptosis and Decrease Proliferation via Transcriptional Regulation
  135. Apigenin and Naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats
  136. Apigenin and Naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats
  137. Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid Naringenin
  138. Application of a regioselective Mannich reaction on Naringenin and its use in fluorescent labeling
  139. Are Naringenin and quercetin useful chemicals in pest-management strategies?
  140. Article Details Assessment of In vitro Naringenin Release from Solid Lipid Nanoparticles and Kinetic Model Profiling: Applied Ultraviolet-Visible Spectrophotometer
  141. Assessment of configurational and conformational properties of Naringenin by vibrational circular dichroism
  142. Assessment of the effects of Naringenin-type flavanones in uterus and vagina
  143. Assessment of the proliferative capacity of the flavanones 8-prenylNaringenin, 6-(1.1-dimethylallyl) Naringenin and Naringenin in MCF-7 cells and the rat mammary …
  144. Assimilation of nod gene inducer 14 C-Naringenin and the incorporation of labelled carbon atoms into the acyl side chain of a host-specific Nod factor produced by …
  145. Attenuation of hepatocellular carcinoma by Naringenin is associated with modulation of circadian rhythms of redox status in rats
  146. Attenuation of NDEA‐induced hepatocarcinogenesis by Naringenin in rats
  147. Attenuation of Obesity, Hepatic Steatosis and Reversal of Atherosclerosis by the Flavonoids Naringenin and Nobiletin
  148. Augmentation Effects of Novel Naringenin Analogues and Ciprofloxacin as Inhibitors for Nora Efflux Pump (EPIs) and Pyruvate Kinase (PK) Against MRSA
  149. Augmented anticancer activity of Naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells
  150. Azorhizobium caulinodans ORS 571–Aspergillus spp. biofilm in the presence of flavonoid Naringenin: An extremely effective association for rice root colonization …
  151. BDNF signaling is necessary for the antidepressant-like effect of Naringenin
  152. Beneficial and detrimental effects of the phytochemical Naringenin on rainbow trout intestinal epithelial cells
  153. Beneficial effects of Naringenin and indomethacin on white and brown adipocytes
  154. Beneficial effects of Naringenin in liver diseases: Molecular mechanisms
  155. Bildung von Naringenin bei der Reife von Tomaten/Formation of Naringenin in Ripening Tomatoes
  156. Binding Interactions of Naringenin and Naringin with Calf Thymus DNA and the Role of β-Cyclodextrin in the Binding
  157. Binding of naringin and Naringenin with hen egg white lysozyme: A spectroscopic investigation and molecular docking study
  158. Binding study of Naringenin derivatives and cyclin dependent kinase 2
  159. Bioactivity of Naringenin in Metabolic Dysregulation and Obesity-Associated Breast Cancer in a Mouse Model of Postmenopause
  160. Bioavailability and pharmacokinetic of the Algerian propolis constituent Naringenin in rats after oral administration
  161. Bioavailability of Naringenin Chalcone in Humans after Ingestion of Cherry Tomatoes
  162. Bioavailability of the flavanone Naringenin and its glycosides in rats
  163. Biochemical and molecular mechanisms of radioprotective effects of Naringenin, a phytochemical from citrus fruits
  164. Biological synthesis of 7-O-methyl apigenin from Naringenin using Escherichia coli expressing two genes
  165. Biotinylated Naringenin intensified anticancer effect of gefitinib in urethane-induced lung cancer in rats: favourable modulation of apoptotic regulators and serum …
  166. Biotransformation of Naringenin by Bacillus amyloliquefaciens Into Three Naringenin Derivatives
  167. Biotransformation of Naringenin to Eriodictyol by Saccharomyces cerevisiea Functionally Expressing Flavonoid 3′ Hydroxylase
  168. Biotransformation of naringin and Naringenin by cultured Eucalyptus perriniana cells
  169. Biphasic effects of the flavonoids quercetin and Naringenin on the metabolic activation of 2-amino-3, 5-dimethylimidazo [4, 5-f] quinoline by Salmonella typhimurium …
  170. Bitter Taste Impact and Thermal Conversion of a Naringenin Glycoside from Cyclopia genistoides
  171. Cadmium-induced hepatotoxicity in rats and the protective effect of Naringenin
  172. Caffeic acid, Naringenin and quercetin enhance glucose‐stimulated insulin secretion and glucose sensitivity in INS‐1E cells
  173. Cardioprotective Efficacy of Naringenin Against Isoproterenol Induced Chronic Heart Failure in a Rat Model
  174. Cascade biocatalysis systems for bioactive Naringenin glucosides and quercetin rhamnoside production from sucrose
  175. Cellular mechanisms underlying the laxative effect of flavonol Naringenin on rat constipation model
  176. Certification of a New Naringenin Reference Material by Coulometric Titrimetry Combined HPLC‐MS
  177. Characteristics of Naringenin Contents in Exocarpium Citri Grandis
  178. CHARACTERIZATION OF Naringenin FROM THE FRUIT PULP EXTRACT OF Parkia biglobosa (FABACEAE)
  179. Characterization, physical stability, and dissolution behavior of Naringenin/mannitol solid dispersions prepared by solvent evaporation method with three drying …
  180. Characterize the interaction between Naringenin and bovine serum albumin using spectroscopic approach
  181. Chemical analysis and pharmacokinetics of the flavonoids quercetin, hesperetin and Naringenin in humans
  182. Chemopreventive and therapeutic potential of “Naringenin,” a flavanone present in citrus fruits
  183. Chemopreventive efficacy of Naringenin-loaded nanoparticles in 7, 12-dimethylbenz (a) anthracene induced experimental oral carcinogenesis
  184. Cholesterol-lowering activity of Naringenin via inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A: cholesterol acyltransferase in rats
  185. Chronic silymarin, quercetin and Naringenin treatments increase monoamines synthesis and hippocampal Sirt1 levels improving cognition in aged rats
  186. Citrus aurantium Naringenin prevents osteosarcoma progression and recurrence in the patients who underwent osteosarcoma surgery by improving antioxidant …
  187. Citrus flavanone Naringenin enhances melanogenesis through the activation of Wnt/β-catenin signalling in mouse melanoma cells
  188. Citrus flavanones Naringenin and hesperetin improve antioxidant status and membrane lipid compositions in the liver of old-aged Wistar rats
  189. Citrus flavanones Naringenin and hesperetin induced mild functional alteration in thyroids of old-aged Wistar rats
  190. Citrus flavonoid Naringenin improves aortic reactivity in streptozotocin-diabetic rats
  191. Citrus flavonoid Naringenin inhibits TLR2 expression in adipocytes
  192. Citrus flavonoid Naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice
  193. Citrus flavonoid, Naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice
  194. Cloning and characterization of Naringenin 8-prenyltransferase, a flavonoid-specific prenyltransferase of Sophora flavescens
  195. Co-treatment of THP-1 cells with Naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways
  196. Cocrystal Formation via Resorcinol–Urea Interactions: Naringenin and Carbamazepine
  197. Cocrystals and a salt of the bioactive flavonoid: Naringenin
  198. Combating oxidative stress disorders with citrus flavonoid: Naringenin
  199. Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin
  200. Combination of Asiatic Acid and Naringenin Inhibits Tumor Progressionby Rebalancing TGF-β/Smad Signaling
  201. Combination of asiatic acid and Naringenin modulates NK cell anti-cancer immunity by rebalancing Smad3/Smad7 signaling
  202. Combinatorial anti-proliferative effects of tamoxifen and Naringenin: The role of four estrogen receptor subtypes
  203. Combinatorial antitumor effect of Naringenin and curcumin elicit angioinhibitory activities in vivo
  204. Combined administration of Naringenin and hesperetin with optimal ratio maximizes the anti-cancer effect in human pancreatic cancer via down regulation of FAK and …
  205. Combined effect of pH and polysorbates with cyclodextrins on solubilization of Naringenin
  206. Combined effects of p-coumaric acid and Naringenin against doxorubicin-induced cardiotoxicity in rats
  207. Comparative in vitro free radical scavenging property of β carotene and Naringenin with respect to vitamin C and N-acetyl cysteine
  208. Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and Naringenin
  209. Comparison of metabolic pharmacokinetics of naringin and Naringenin in rabbits
  210. Comparison of the citrus flavonoid Naringenin and metformin for effects on breast cancer in obese ovariectomized mice
  211. Competitive adsorption equilibrium model with continuous temperature dependent parameters for Naringenin enantiomers on Chiralpak AD column
  212. Configuration of stereoisomers of Naringenin 5-glucoside present in flamin
  213. Conformational Study of Naringenin in the Isolated and Solvated States by Semiempirical and Ab Initio Methods
  214. Content of CYP3A4 inhibitors, naringin, Naringenin and bergapten in grapefruit and grapefruit juice products
  215. Context- and dose-dependent modulatory effects of Naringenin on survival and development of Drosophilamelanogaster
  216. Conversion of Naringenin and hesperetin by heterogeneous catalytic Baeyer–Villiger reaction into lactones exhibiting apoptotic activity
  217. Coordination ability and biological activity of a Naringenin thiosemicarbazone
  218. Coordination reactions of transition metal copper (Ⅱ) Ions with Naringenin
  219. Copper (II) and 2, 2′-bipyridine complexation improves chemopreventive effects of Naringenin against breast tumor cells
  220. Copper (II) complexes with Naringenin and hesperetin: cytotoxic activity against A 549 human lung adenocarcinoma cells and investigation on the mode of action
  221. Correction: Enhancement of Naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin
  222. Corrigendum to “Naringenin protects against acute pancreatitis in two experimental models in mice by NLRP3 and Nrf2/HO-1 pathways”
  223. Corrigendum: The citrus flavanone Naringenin impairs dengue virus replication in human cells
  224. Covalent attachment of the plant natural product Naringenin to small glass and ceramic beads
  225. Critical insight into the interaction of Naringenin with human haemoglobin: A combined spectroscopic and computational modeling approaches
  226. Cysteine conjugated chitosan based green nanohybrid hydrogel embedded with zinc oxide nanoparticles towards enhanced therapeutic potential of Naringenin
  227. Cytoprotective, antihyperglycemic and antioxidative effect of Naringenin on liver and kidneys of Swiss diabetic mice
  228. Cytotoxic effects of 7-O-butyl Naringenin on human breast cancer MCF-7 cells
  229. Cytotoxic, genotoxic and apoptotic effects of Naringenin-oxime relative to Naringenin on normal and cancer cell lines
  230. De novo production of the flavonoid Naringenin in engineered Saccharomyces cerevisiae
  231. Defensive Effects Of Naringenin Against Gamma Rays-Induced Acute Renal Insufficiency In Rats
  232. Degradation of hesperetin and Naringenin to phloroglucinol
  233. Denatonium and Naringenin promote SCA-9 tumor growth and angiogenesis: participation of arginase
  234. Design and Characterization of Biosensors for the Screening of Modular Assembled Naringenin Biosynthetic Library in Saccharomyces cerevisiae
  235. Design, synthesis and inhibitory activities of Naringenin derivatives on human colon cancer cells
  236. Detection and quantification of Naringenin and kaempferol in Melastoma decemfidum extracts by GC-FID and GC-MS
  237. Detection of Naringenin and Kaempferol in Justicia gendarussa Leaf Extracts by GC-FID
  238. Determination of Anti-Cancer Effects of Poly (DL-Lactide-co-Glycolide)-Block-Poly (Ethylene Glycol) Nanocarrier Loaded with Naringenin
  239. Determination of cytotoxic, genotoxic and oxidative effects of Naringenin
  240. Determination of Naringenin and Apigenin in Premna fulva Craib. by HPLC
  241. Determination of Naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography
  242. Determination of Naringenin Enantiomers Adsorption Equilbrium on Chiralpak AD Column
  243. Determination of Naringenin in Dendrobium officinale by HPLC
  244. Determination of Naringenin levels in Phellinus vaninii by reversed-phase high-performance liquid chromatography.
  245. Determination of Naringenin-7-O-glucoside and eriodictyol-7-O-glucoside in Dracocephalum rupestra and its different parts by HPLC
  246. Determination of naringin and Naringenin in human plasma by high-performance liquid chromatography
  247. Determination of naringin and Naringenin in human urine by high-performance liquid chromatography utilizing solid-phase extraction
  248. Determination of Naringin and Naringenin in Rat Liver Microsomes by UPLC
  249. Determination of rutin, quercetin, Naringenin and hesperetin in the honey from Bosnia and Herzegovina (B & H) in relation to the composition of pollen
  250. Determination of synephrine and Naringenin in aifunuangong pills by high performance capillary electrophoresis
  251. Determination of the binding rate of Naringenin flavonoid to plasma proteins.
  252. Determination of the Naringenin in Xiao’er Jindan Tablet by Capillary Zone Electrophoresis
  253. Determination the Content of Naringenin in Compound Rhubarb Oral Solution by HPLC
  254. Determining stability constants of Naringenin (4′, 5, 7-trihydroxy flavanone) complexes with aluminium (III) and iron (II) by potentiometric and spectrophotometric …
  255. Development and evaluation of simultaneous quantification of naringin, prunin, Naringenin, and limonin in citrus juice
  256. Development and optimization of an in vitro multienzyme synthetic system for production of kaempferol from Naringenin
  257. Development and validation of a RP-HPLC method to quantify Naringenin in Lecithin/Chitosan nano-and microparticle suspensions
  258. Development and validation of a RP-UHPLC-ESI-MS/MS method for the chiral separation and determination of flavanone, Naringenin and hesperetin enantiomers
  259. Development and validation of two new sensitive ELISAs for Hesperetin and Naringenin in biological fluids
  260. Development of a food frequency questionnaire for the assessment of quercetin and Naringenin intake
  261. Development of Artificial Riboswitches for Monitoring of Naringenin In Vivo
  262. Development of Nanophytoformulations of curcumin and Naringenin for improving their bioavailability and anticancer efficacy in colorectal cancer
  263. Development of riboswitch-based sensor device that specifically respond to intracellular concentration of Naringenin through in vivo and in vitro selection
  264. DFT Studies on the Antioxidant Activity of Naringenin and Its Derivatives: Effects of the Substituents at C3
  265. Dichotomous effect of caffeine, curcumin, and Naringenin on genomic DNA of normal and diabetic subjects
  266. Dietary apigenin and Naringenin protect against colon carcinogenesis by lowering high multiplicity aberrant crypt foci and enhancing apoptosis in azoxymethane …
  267. Dietary flavonoid Naringenin induces regulatory T cells via an aryl hydrocarbon receptor mediated pathway
  268. Dietary Naringenin increases hepatic peroxisome proliferators–activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats
  269. Dietary Naringenin supplementation attenuates experimental autoimmune encephalomyelitis by modulating autoimmune inflammatory responses in mice
  270. Dietary phytophenols curcumin, Naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and …
  271. Dietary supplementation with Naringenin attenuates experimental autoimmune encephalomyelitis in mice
  272. Differential angiogenic activities of naringin and Naringenin in zebrafish in vivo and human umbilical vein endothelial cells in vitro
  273. Direct actions of the flavonoids Naringenin, quercetin and genistein on rat cardiac and vascular muscles
  274. Discrimination of the rare medicinal plant Dendrobium officinale based on Naringenin, bibenzyl, and polysaccharides
  275. Disposition of Naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides
  276. Dissolution rate and stability study of flavanone aglycones, Naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions
  277. Distinct effects of Naringenin and hesperetin on nitric oxide production from endothelial cells
  278. DNA Interactions of Polymerized Schiff Base Ligand and Its Complexes Obtained from Naringenin
  279. DNA-protective effects of quercetin or Naringenin in alloxan-induced diabetic mice
  280. Does consumption of red grapefruit juice alter Naringenin concentrations in milk produced by breastfeeding mothers?
  281. Echiofruzine, a novel Naringenin diglycoside from Echiochilon fruticosum growing in Tunisia
  282. EETs/PPARs activation together mediates the preventive effect of Naringenin in high glucose-induced cardiomyocyte hypertrophy
  283. Effect of Acetylation and Beta‐Amylase Treatment on Complexation of Debranched Starch with Naringenin
  284. Effect of adding extracted hesperetin, Naringenin and pectin on egg cholesterol, serum traits and antioxidant activity in laying hens
  285. Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection
  286. Effect of apigenin-7-glucoside, genkwanin and Naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells
  287. Effect of citrus flavonoids, naringin and Naringenin, on metabolic syndrome and their mechanisms of action
  288. Effect of complex formation by taxifolin and Naringenin with Cu (i) ions on the distribution of the components of complexes in the octanol–water system
  289. Effect of crocin and Naringenin supplementation in cryopreservation medium on post-thawed rooster sperm quality and expression of apoptosis associated genes
  290. Effect of diabetes on brain glycosaminoglycans and their modulation by quercetin and Naringenin
  291. Effect of Dietary Flavonoid Naringenin on Bones in Rats with Ovariectomy-Induced Osteoporosis
  292. Effect of different compatibility of zhizi dahuang decoction on pharmacokinetics of Naringenin and hesperetin
  293. Effect of domestic cooking on human bioavailability of Naringenin, chlorogenic acid, lycopene and β-carotene in cherry tomatoes
  294. Effect of External Factors on the Content of Polyphenols and Naringenin in the Pine Needles
  295. Effect of grapefruit juice, naringin, Naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats
  296. Effect of heated Naringenin on immunomodulatory properties and cellular antioxidant activity
  297. Effect of Low Temperature and Rh izospheric Application of Naringenin on Pea-Rhizobium leguminosarum biovar viciae Symbiosis
  298. Effect of mobile phone electromagnetic waves on rat testis and the possible ameliorating role of Naringenin: A histological study
  299. Effect of nanocapsules with naringin and Naringenin on oxidative stress parameters in rats stomach
  300. Effect of Naringenin (a naturally occurring flavanone) against pilocarpine-induced status epilepticus and oxidative stress in mice
  301. Effect of Naringenin (citrus flavanone) on lipid profile in ethanol‐induced toxicity in rats
  302. Effect of Naringenin in Qianggu capsule on population pharmacokinetics in Chinese women with primary osteoporosis
  303. Effect of Naringenin on 3-NP Induced Huntington’s disease like Symptoms by Estimations of Motor Co-ordination and Behavioral Parameters
  304. Effect of Naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats
  305. Effect of Naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis
  306. Effect of Naringenin on KIM-1 expression in rats with renal interstitial fibrosis caused by unilateral ureteral obstruction
  307. Effect of Naringenin on learning and memory ability on model rats with Alzheimer disease
  308. Effect of Naringenin on lipids, lipoproteins and lipid metabolising enzymes in 7, 12-dimethyl benz (a) anthracene-induced mammary carcinogenesis in SD rats
  309. Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat’s brain
  310. Effect of Naringenin on NaIO3-induced retinal pigment epithelium degeneration and laser-induced choroidal neovascularization in rats
  311. Effect of Naringenin on the growth and lignin biosynthesis of gramineous plants
  312. Effect of Naringenin, hesperetin and their glycosides forms on the replication of the 17D strain of yellow fever virus
  313. Effect of Naringenin, Quercetin, and Sesamin on Xenobiotica-Metabolizing CYP1A and CYP3A in Mice Offspring after Maternal Exposure to Persistent Organic …
  314. Effect of naringin and Naringenin on contractions induced by noradrenaline in rat vas deferens–I. Evidence for postsynaptic alpha-2 adrenergic receptor.
  315. Effect of naringin enzymatic hydrolysis towards Naringenin on the anti-inflammatory activity of both compounds
  316. Effect of pH on the reaction between Naringenin and methylglyoxal: A kinetic study
  317. Effect of quercetin, Naringenin & EGCG on α1-adrenergic receptor-mediated vascular contraction in pulmonary artery of goat (Capra hircus)
  318. Effect of quercetin, rutin, Naringenin and epicatechin on lipid peroxidation induced in human sperm
  319. Effect of R. leguminisarum pre-incubated with inducers, Naringenin and methyl-jasmonate, on nitrogen fixation and the growth of pea at different salinity levels
  320. Effect of simvastatin and Naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study
  321. Effect of sodium Naringenin monosulfate on thrombosis and platelet aggregation
  322. Effect of temperature, pH, β-and HP-β-cds on the solubility and stability of flavanones: Naringenin and hesperetin
  323. Effect of the citrus flavanone Naringenin on oxidative stress in rats
  324. Effect of Zinc Oxide Nanoparticles on the Structure of Testis of Adult Albino Rats and the Possible Protective Role of Naringenin
  325. Effects of Chemical and Enzymatic Modifications on Starch and Naringenin Complexation
  326. Effects of Chemical and Enzymatic Modifications on Starch and Naringenin Complexation
  327. Effects of Naringenin and its phase II metabolites on in vitro human macrophage gene expression
  328. Effects of Naringenin and quercetin on experimental chronic gastric ulcer in rat. Studies on the histological findings
  329. Effects of Naringenin and silymarin on urinary excretion of water and electrolytes in rats
  330. Effects of Naringenin on allodynia and hyperalgesia in rats with chronic constriction injury-induced neuropathic pain.
  331. Effects of Naringenin on glucose uptake in L6 skeletal muscle cells
  332. Effects of Naringenin on inflammation in complete freund’s adjuvant-induced arthritis by regulating Bax/Bcl-2 balance
  333. Effects of Naringenin on Learning and Memory Disorder and β-amyloid Peptide Induced Neurotoxicity in Rats [J]
  334. Effects of Naringenin on lipogenesis, lipolysis and glucose uptake in rat adipocyte primary culture: a natural antidiabetic agent
  335. Effects of Naringenin on mucous hypersecretion in the airway inflammation [J]
  336. Effects of Naringenin on ocular blood flow and choroidal neovascularization in experimental animals
  337. Effects of Naringenin on oxidative stress and histopathological changes in the liver of lead acetate administered rats
  338. Effects of Naringenin on renal expression of organic cation transporter 1 and 2 proteins and metformin disposition in diabetic rats
  339. Effects of Naringenin on vascular changes in prolonged hyperglycaemia in fructose-STZ diabetic rat model
  340. Effects of nitrogen application rate on the Naringenin exudation from intercropped faba bean’s roots in different separation patterns
  341. Effects of quercetin and Naringenin on rate and force of contraction of isolated rat right and left atria
  342. Effects of quercetin, Naringenin and EGCG on 5HT and histamine induced contraction in pulmonary artery and its modulation by hypoxia
  343. Effects of root‐applied Naringenin and chalcone on the growth of annual plants
  344. Effects of supplemental levels of hesperetin and Naringenin on egg quality, serum traits and antioxidant activity of laying hens
  345. Effects of the chemically synthesized flavanone 7-(O-prenyl) Naringenin-4′-acetate on the estrogen signaling pathway in vivo and in vitro
  346. Effects of the Flavanone combination Hesperetin‐Naringenin, and Orange and Grapefruit Juices, on Airway inflammation and Remodeling in a murine asthma model
  347. Efficacy of Naringenin against permethrin‐induced testicular toxicity in rats
  348. Efficient biosynthesis of (2S)-Naringenin from p-coumaric acid in Saccharomyces cerevisiae
  349. Efficient biosynthesis, analysis, solubility and anti-bacterial activities of succinylglycosylated Naringenin
  350. Efficient nickel (ii) Naringenin-oxime complex catalyzed Mizoroki–Heck cross-coupling reaction in the presence of hydrazine hydrate
  351. Electrochemical behavior of Naringenin and its sensitive determination based on a single-walled carbon nanotube modified electrode
  352. Electrochemical determination of copper (II) ions at Naringenin-modified glassy carbon electrode: Application in lake water sample
  353. Electrochemical Study of Naringenin-DNA Interaction on Modified DNA-PAH-MPA Gold Electrode
  354. Empirical study of Naringenin inhibiting body weight of high fat diet obese rats [J]
  355. Enantiomers of Naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms
  356. Enantioselective Modulatory Effects of Naringenin Enantiomers on the Expression Levels of miR‐17‐3p Involved in Endogenous Antioxidant Defenses
  357. Encapsulation of Naringenin using zein nanoparticles
  358. Encapsulation of rutin and Naringenin in multilamellar vesicles for optimum antioxidant activity
  359. Engineerigng E. coli-E. coli co-cultures for the production of Naringenin
  360. Enhanced action of apigenin and Naringenin combination on estrogen receptor activation in non-malignant colonocytes: implications on sorghum-derived …
  361. Enhanced anticancer activity of Naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells
  362. Enhanced anticancer effect of ABT-737 in combination with Naringenin on gastric cancer cells
  363. Enhanced cellular cholesterol efflux by Naringenin is mediated through inhibiting endoplasmic reticulum stress-ATF6 activity in macrophages
  364. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier
  365. Enhanced oral bioavailability of felodipine by Naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro
  366. Enhanced oral bioavailability of Naringenin administered in a mixed micelle formulation with Pluronic F127 and Tween 80 in rats
  367. Enhanced Solubility and Bioavailability of Naringenin via Liposomal Nanoformulation: Preparation and In Vitro and In Vivo Evaluations
  368. Enhanced stability of a Naringenin/2, 6-dimethyl β-cyclodextrin inclusion complex: Molecular dynamics and free energy calculations based on MM-and QM-PBSA …
  369. Enhanced therapeutic potential of Naringenin‐phospholipid complex in rats
  370. Enhancement of Naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin
  371. Enhancement of Naringenin Biosynthesis from Tyrosine by Metabolic Engineering of Saccharomyces cerevisiae
  372. Enhancement of Naringenin solution concentration by solid dispersion in cellulose derivative matrices
  373. Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids Naringenin and hesperitin correlate to reduction of the in …
  374. Enzymatic properties of cytochrome P450 catalyzing 3′-hydroxylation of Naringenin from the white-rot fungus Phanerochaete chrysosporium
  375. Enzymatic synthesis of aromatic compounds in higher plants: Formation of Naringenin (5, 7, 4′‐trihydroxyflavanone) from p‐coumaroyl coenzyme A and malonyl …
  376. Enzymatic synthesis of the flavone glucosides, prunin and isoquercetin, and the aglycones, Naringenin and quercetin, with selective-l-rhamnosidase and-d …
  377. Enzymatically enriching Naringenin with hydroxylated and/or methoxylated phenolic compounds
  378. Erectile dysfunction attenuation by Naringenin in streptozotocin‐induced diabetic rats
  379. Eriodictyol and Naringenin inhibit the formation of AGEs: An in vitro and molecular interaction study
  380. Estimation of safety/risk profile of the phytoestrogens 8-prenylNaringenin, 6-(1.1-dimethylallyl) Naringenin and Naringenin in MCF-7 cells and the rat mammary gland
  381. Estrogenic activity of the phytoestrogens Naringenin, 6-(1, 1-dimethylallyl) Naringenin and 8-prenylNaringenin
  382. Evaluation of Anti-inflammatory and Regenerative Efficiency of Naringin and Naringenin in Degenerated Human Nucleus Pulposus Cells: Biological and …
  383. Evaluation of Diuretic and Urine Electrolyte Effects of Naringenin in Hypercholesterolemic Rats
  384. Evaluation of Naringenin and quercetin as modulators of energy sensing Network under insulin Resistant Condition A comparative study with Metformin
  385. EVALUATION OF Naringenin ROLE IN INHIBITON OF LUNG TUMOR PROGRESSION IN MICE
  386. Evaluation of the chemopreventive response of Naringenin-loaded nanoparticles in experimental oral carcinogenesis using laser-induced autofluorescence …
  387. Evaluation of the diuretic potentials of Naringenin in hypercholesterolemic rats
  388. Evaluation of the effect of Naringenin on pentylenetetrazole and maximal electroshock-induced convulsions in mice
  389. Evaluation of the interaction between Naringenin and human serum albumin: Insights from fluorescence spectroscopy, electrochemical measurement and molecular …
  390. Evaluation of the possible protective role of Naringenin on gentamicin-induced ototoxicity: A preliminary study
  391. Evaluation of the potential interaction between methylmercuric chloride and Naringenin on pre-and postnatal rat development
  392. Evaluation of the protective effects of quercetin, rutin, Naringenin, resveratrol and trolox against idarubicin-induced DNA damage
  393. Evaluation of the Protective Effects of Quercetin, Rutin, Naringenin, Resveratrol and Trolox Against Idarubicin-Induced DNA…
  394. Evidence for the Specific Molecular Interactions Between Naringenin, NODD and nod-promoter
  395. Evidence of the specific molecular interactions between Naringenin, NODD and nod-promoter.
  396. Exploration of simultaneous determination for Naringenin and eriodictyol in etiolation tissues of fresh-cut Chinese water-chestnut
  397. Exploring binding properties of Naringenin with bovine β-lactoglobulin: A fluorescence, molecular docking and molecular dynamics simulation study
  398. Exploring the interaction of Naringenin with bovine beta-casein nanoparticles using spectroscopy
  399. Exploring the interactions of the dietary plant flavonoids fisetin and Naringenin with G-quadruplex and duplex DNA, showing contrasting binding behavior …
  400. Fabrication of surfactant-stabilized nanosuspension of Naringenin to surpass its poor physiochemical properties and low oral bioavailability
  401. Fast, simple and efficient salting-out assisted liquid-liquid extraction of Naringenin from fruit juice samples prior to their enantioselective determination by liquid …
  402. Features of apigenin, luteolin, hesperetin and Naringenin in crop and body
  403. FIA–Spectrophotometric methods for the determination of Naringenin in supplements and urine samples using diazotization coupling reactions
  404. Fine-tuning of the fatty acid pathway by synthetic antisense RNA for enhanced (2S)-Naringenin production from L-tyrosine in Escherichia coli
  405. Fine‐tuning the (2S)‐Naringenin synthetic pathway using an iterative high‐throughput balancing strategy
  406. Flavanone Naringenin: An effective antihyperglycemic and antihyperlipidemic nutraceutical agent on high fat diet fed streptozotocin induced type 2 diabetic rats
  407. Flavonoid Naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina
  408. Flavonoid Naringenin: a potential immunomodulator for Chlamydia trachomatis inflammation
  409. Flavonoid: a review on Naringenin
  410. Flow Injection Spectrophotometric Determination of Naringenin in Supplements using solid-phase reactor containing immobilized manganese dioxide
  411. Formation of the inclusion complex of water soluble fluorescent calix [4] arene and Naringenin: solubility, cytotoxic effect and molecular modeling studies
  412. Formulation and evaluation of Naringenin nanosuspensions for bioavailability enhancement
  413. Formulation and evaluation of polymeric nanosuspension of Naringenin
  414. Formulation, characterization and pharmacokinetic evaluation of Naringenin-loaded gastroretentive mucoadhesive polymeric nanosystem for oral drug delivery
  415. FT-IR analysis on the inclusion complex of Β-Cyclodextrin with quercetin, Naringenin, 3-Hydroxyflavone and chrysin via different preparation methods
  416. FT‐Raman and FT‐IR spectral and quantum chemical studies on some flavonoid derivatives: Baicalein and Naringenin
  417. Gelatin-coated Polycaprolactone nanoparticle-mediated Naringenin delivery rescue human mesenchymal stem cells from oxygen glucose deprivation-induced …
  418. Genetic and functional characterization of a novel meta‐pathway for degradation of Naringenin in Herbaspirillum seropedicae SmR1
  419. Genetic expression profile analysis of the temporal inhibition of quercetin and Naringenin on Lactobacillus rhamnosus GG
  420. Genome wide transcriptional profiling of Herbaspirillum seropedicae SmR1 grown in the presence of Naringenin
  421. Ghrelin receptor is activated by naringin and Naringenin, constituents of a prokinetic agent Poncirus fructus
  422. Gibbs energies of protonation and complexation of platinum and vanadate metal ions with Naringenin and phenolic acids: Theoretical calculations associated with …
  423. Glucuronidation of Naringenin in rats
  424. Grapefruit Flavonoid Naringenin Regulates the Expression of LXRα in THP-1 Macrophages by Modulating AMP-Activated Protein Kinase
  425. Grapefruit phenolics—I.: Identification of dihydrokaempferol and its co-occurrence with Naringenin and kaempferol
  426. Growth inhibitory and chemo-sensitization effects of Naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer
  427. Hepato & nephro protective effects of Naringenin-loaded tpgs polymeric nanosuspension against cisplatin-induced toxicity
  428. Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, Naringenin, via inhibition of MTP-mediated microsomal triglyceride …
  429. Hepatolipidemic effects of Naringenin in high cornstarch-versus high coconut oil-fed rats
  430. Hepatoprotective effect and antioxidant capacity of Naringenin on arsenic induced liver injury in rats
  431. Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 tyrosine kinase inhibitors
  432. Hesperetin and Naringenin: Protective effects against metabolic syndrome–associated inflammation
  433. Heterologous biosynthesis of natural product Naringenin by co-culture engineering
  434. High-performance liquid chromatographic separation and chiroptical properties of the enantiomers of Naringenin and other flavanones
  435. Highly purified “flavanone synthase” from parsley catalyzes the formation of Naringenin chalcone
  436. Hyaluronic acid decorated Naringenin nanoparticles: Appraisal of chemopreventive and curative potential for lung cancer
  437. Hydroxylation of diverse flavonoids by CYP450 BM3 variants: biosynthesis of eriodictyol from Naringenin in whole cells and its biological activities
  438. Hydroxylation of kaempferol, dihydrokaempferol and Naringenin by a phenolase preparation from spinach beet
  439. Hydroxypropyl-β-cyclodextrin-complexed Naringenin by solvent change precipitation for improving anti-inflammatory effect in vivo
  440. Hypocholesterolemic and antioxidative effects of Naringenin and its two metabolites in high-cholesterol fed rats
  441. Hypoglycemic and Insulin Sensitizing Effect of Naringenin on High Fat Diet Fed, Streptozotocin Induced Type 2 Diabetic Rats
  442. Hypolipidaemic effects of Naringenin, rutin, nicotinic acid and their associations.
  443. I3-Naringenin-II8-4′-OMe-eriodictyol: a New Potential Analgesie Agent Isolated from Rheedia gardneriana Leaves
  444. Identification and quantification of metabolites of orally administered Naringenin chalcone in rats
  445. Identification and quantification of Quercetin, Naringenin and Hesperetin by RP LC–DAD in honey samples from B&H
  446. Identification of a Polygonum cuspidatum three-intron gene encoding a type III polyketide synthase producing both Naringenin and p-hydroxybenzalacetone
  447. Identification of gene-phenotype connectivity associated with flavanone Naringenin by functional network analysis
  448. Identification of Sternbin and Naringenin as Detoxified Metabolites from the Rice Flavanone Phytoalexin Sakuranetin by Pyricularia oryzae
  449. Immunotherapeutic potential of Codonopsis clematidea and Naringenin against visceral leishmaniasis
  450. Impact of Naringenin on oxytetracycline-mediated oxidative damage in kidney of rats
  451. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (±)-Naringenin
  452. Improved antioxidant, antimicrobial and anticancer activity of Naringenin on conjugation with pectin
  453. Improved Oxidation of Naringenin to Carthamidin and Isocarthamidin by Rhodotorula marina
  454. Improving Rooster Sperm Quality by Adding Different Levels of Naringenin after Freezing-Thawing Process
  455. In vitro analysis of phytochemicals epicatechin, Naringenin, myricetin against Hep3B cell lines and VERO cell lines
  456. In vitro antiviral activity of fisetin, rutin and Naringenin against dengue virus type-2
  457. In vitro effect of 8-prenylNaringenin and Naringenin on fibroblasts and glioblastoma cells-cellular accumulation and cytotoxicity
  458. In vitro effects of diosmin, Naringenin, quercetin and indole-3-carbinol on fish hepatic CYP1A1 in the presence of clotrimazole and dexamethasone
  459. In vitro effects of myricetin, morin, apigenin,(+)-taxifolin,(+)-catechin,(−)-epicatechin, Naringenin and naringin on cytochrome b5 reduction by purified NADH …
  460. In vitro effects of the citrus flavonoids diosmin, Naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish
  461. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by Naringenin and other flavonoids
  462. In vitro inhibition of simvastatin metabolism in rat and human liver by Naringenin
  463. In Vitro Naringenin Biosynthesis from p-Coumaric Acid Using Recombinant Enzymes
  464. In vitro neuroprotective effects of Naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation
  465. In vitro observation of the molecular interaction between NodD and its inducer Naringenin as monitored by fluorescence resonance energy transfer
  466. In vivo and in vitro antioxidative efficacy of Naringenin on cadmium-induced toxicity in rats
  467. In Vivo Anti-inflammatory and Antiallergic Activity of Pure Naringenin, Naringenin Chalcone, and Quercetin in Mice
  468. In vivo metabolic effects of Naringenin in the ethanol consuming rat and the effect of Naringenin on adipocytes in vitro
  469. Inactivation of Escherichia coli O157: H7 in apple cider by resveratrol and Naringenin
  470. Inclusion Complexes of Naringenin in Dimethylated and Permethylated β-Cyclodextrins: Crystal Structures and Molecular Dynamics Studies
  471. Increased Cytotoxic Effect of Doxorubicin by Naringenin on T47D Cancer Cells through Apoptosis Induction
  472. Induction of apoptosis and antiproliferative activity of Naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest
  473. Induction of apoptotic cell death by synthetic Naringenin derivatives in human lung epithelial carcinoma A549 cells
  474. Influence of Naringenin adaptation and shock on resistance of Staphylococcus aureus and Escherichia coli to pulsed electric fields
  475. Influence of Naringenin on oxytetracycline mediated oxidative damage in rat liver
  476. Influence of Naringenin on the activity of enzymes participating in steroidogenesis in male rats.
  477. Influence of Naringenin on the biofilm formation of Streptococcus mutans
  478. Influence of quercetin, Naringenin and berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats
  479. Infrared and DNA-binding on ultraviolet and fluorescence spectra of new copper and zinc complexes with a Naringenin Schiff-base ligand
  480. Inhibition of 11β-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furoemide, Naringenin and some other compounds
  481. Inhibition of apoB secretion from HepG2 cells by insulin is amplified by Naringenin, independent of the insulin receptor
  482. Inhibition of cardiac HERG channels by grapefruit flavonoid Naringenin: implications for the influence of dietary compounds on cardiac repolarisation
  483. Inhibition of chikungunya virus replication by hesperetin and Naringenin
  484. Inhibition of guinea pig intestinal peristalsis by the flavonoids quercetin, Naringenin, apigenin and genistein
  485. Inhibition of hepatocyte apoB secretion by Naringenin enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters
  486. Inhibition of intestinal and renal Na+-glucose cotransporter by Naringenin
  487. Inhibition of LPS induced pro-inflammatory responses in RAW 264.7 macrophage cells by PVP-coated Naringenin nanoparticle via down regulation of NF-κB …
  488. Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid Naringenin and by insulin involves activation …
  489. Inhibition of Naringenin complex with β-cyclodextrin on experimental choroidal neovascularization in rats
  490. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid Naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin …
  491. Inhibition of the MAPK pathway alone is insufficient to account for all of the cytotoxic effects of Naringenin in MCF-7 breast cancer cells
  492. Inhibition of α-toxin production by subinhibitory concentrations of Naringenin controls Staphylococcus aureus pneumonia
  493. Inhibitory effect of GB-2a (I3-Naringenin-II8-eriodictyol) on melanogenesis
  494. Inhibitory effect of grapefruit juice and its bitter principal, Naringenin, on CYP1A2 dependent metabolism of caffeine in man.
  495. Inhibitory effect of hesperetin and Naringenin on human UDP-glucuronosyltransferase enzymes: implications for herb–drug interactions
  496. Inhibitory effect of Naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats
  497. Inhibitory effect of Naringenin chalcone on inflammatory changes in the interaction between adipocytes and macrophages
  498. Inhibitory effect of Naringenin in airway mucus hypersecretion and the possible mechanism
  499. Inhibitory effect of Naringenin on LPS-induced skin senescence by SIRT1 regulation in HDFs
  500. Inhibitory effect of Naringenin on MMP-2,-9 activity and expression in HT-1080 cells
  501. Inhibitory Effect of Naringenin on MMP-9 Activity and Expression in HT-1080 Cells
  502. Inhibitory effect of Naringenin via IL‐13 level regulation on thymic stromal lymphopoietin‐induced inflammatory reactions
  503. Inhibitory effects of Naringenin and its novel derivatives on hyaluronidase
  504. Inhibitory effects of Naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice
  505. Inhibitory mechanism of Naringenin against carcinogenic acrylamide formation and nonenzymatic browning in Maillard model reactions
  506. Insights into the mechanisms underlying the antitumor activity of an oxidovanadium (IV) compound with the antioxidant Naringenin. Albumin binding studies
  507. Interactions of the flavonoid Naringenin in the gastrointestinal tract and the influence of glycosylation
  508. Intervention with Naringenin Enhances Weight Loss, Potentiates Improvements in Metabolic Dysregulation and Halts Progression of Atherosclerosis Induced by a …
  509. Investigation of the anxiolytic effects of Naringenin, a component of Mentha aquatica, in the male Sprague-Dawley rat
  510. Investigation of the effect of Naringenin on oxidative stress‐related alterations in testis of hydrogen peroxide‐administered rats
  511. Investigation of the protective effect of Naringenin on the cisplatin-induced nephrotoxicity in rats.
  512. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid Naringenin in mice
  513. Isolated mangiferin and Naringenin exert antidiabetic effect via PPARγ/GLUT4 dual agonistic action with strong metabolic regulation
  514. Isolation and identification of two isomeric Naringenin rhamnodiglucosides from grapefruit
  515. Isolation of the MAO-inhibitor Naringenin from Mentha aquatica L.
  516. Kinetic solvent effects on the reaction between flavonoid Naringenin and 2, 2-diphenyl-1-picrylhydrazyl radical in different aqueous solutions of ethanol: An …
  517. Kinetic-spectrophotometric Method for the Determination of Naringenin in Pure and Supplements Formulations
  518. Kinetics and mechanism of Naringenin reaction with Ce (IV) in different aqueous solutions of dimethylsulfoxide
  519. L-Phenylalanine ammonia-lyase activity and Naringenin glycoside accumulation in developing grapefruit
  520. LC/MS/MS quantitation assay for pharmacokinetics of Naringenin and double peaks phenomenon in rats plasma
  521. Lead-induced oxidative stress and protective effect of Naringenin on testis tissues of rats
  522. Lethal and teratogenic effects of Naringenin evaluated by means of an amphibian embryo toxicity test (AMPHITOX)
  523. Levels of endogenous gibberellins, abscisic acid, indol 3 acetic acid, and Naringenin during dormancy of peach flower buds
  524. Lipid peroxidation and DNA damage induced by morin and Naringenin in isolated rat liver nuclei
  525. Mangiferin and Naringenin affect the photostability and phototoxicity of sunscreens containing avobenzone
  526. Mechanism of inhibition of CYP1A1 and glutathione S-transferase activities in fish liver by quercetin, resveratrol, Naringenin, hesperidin, and rutin
  527. Mechanisms of Naringenin‐induced Apoptotic Cascade in Cancer Cells: Involvement of Estrogen Receptor a and ß Signalling
  528. Membrane and genomic DNA dual-targeting of citrus flavonoid Naringenin against Staphylococcus aureus
  529. Mesenteric lymphatic absorption and the pharmacokinetics of naringin and Naringenin in the rat
  530. Metabolic engineering of Escherichia coli for enhanced production of Naringenin 7-sulfate and its biological activities
  531. Metabolic engineering of Escherichia coli for the biological synthesis of 7-O-xylosyl Naringenin
  532. Metabolic profile of Naringenin in the stomach and colon using liquid chromatography/electrospray ionization linear ion trap quadrupole-Orbitrap-mass spectrometry …
  533. Metabolism of administered (2RS)-Naringenin in flavonoid-producing cultured cells of Sophora flavescens
  534. Metabolism of Quercetin and Naringenin by Food-Grade Fungal Inoculum, Rhizopus azygosporus Yuan et Jong (ATCC 48108)
  535. Metal-ligand coordination and antiradical activity of a trichromium (III) complex with the flavonoid Naringenin
  536. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of Naringenin: Molecular and pharmacological insights
  537. Methylated flavonoids as anti-seizure agents: Naringenin 4′, 7-dimethyl ether attenuates epileptic seizures in zebrafish and mouse models
  538. Microbial metabolism of prenylated Naringenin derivatives
  539. Microbial transformation of Naringenin derivatives
  540. Minor effects of the citrus flavonoids naringin, Naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats
  541. Modular optimization of heterologous pathways for de novo synthesis of (2S)-Naringenin in Escherichia coli
  542. Modularization and response curve engineering of a Naringenin-responsive transcriptional biosensor
  543. Modulating heterologous pathways and optimizing fermentation conditions for biosynthesis of kaempferol and astragalin from Naringenin in Escherichia coli
  544. Modulation of antioxidant status and cell signaling for radioprotection by Naringenin: a phytochemical from citrus fruits
  545. Modulation of major histocompatibility complex (MHC) class i heavy chain gene expression by Naringenin in cells that express human papillomavirus (HPV) E6 and …
  546. Modulation of plant slow vacuolar (SV) channel by flavonoid Naringenin
  547. Modulation of the growth and metabolic response of cyanobacteria by the multifaceted activity of Naringenin
  548. MODULATORY EFFECT OF Naringenin ON N‐METHYL‐N′‐NITRO‐N‐NITROSOGUANIDINE‐ AND SATURATED SODIUM CHLORIDE‐INDUCED GASTRIC …
  549. Molecular binding response of naringin and Naringenin to H46R mutant SOD1 protein in combating protein aggregation using density functional theory and discrete …
  550. Molecular genetics of Naringenin biosynthesis, a typical plant secondary metabolite produced by Streptomyces clavuligerus
  551. Molecular interaction of naringin and its metabolite Naringenin to human liver fibrosis proteins: An In Silico approach
  552. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, Naringenin, and acyl phloroglucinol derivatives
  553. Muscanone: a 3-O-(1 ″, 8 ″, 14 ″-trimethylhexadecanyl) Naringenin from Commiphora wightii
  554. Myricetin and Naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro
  555. Nanoliposome improves inhibitory effects of Naringenin on nonalcoholic fatty liver disease in mice
  556. Naringenin (4, 5, 7‐trihydroxyflavanone) suppresses the development of precancerous lesions via controlling hyperproliferation and inflammation in the colon of …
  557. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells
  558. Naringenin (NAR) and 8-prenylNaringenin (8-PN) reduce the developmental competence of porcine oocytes in vitro
  559. Naringenin 7-O-cetyl ether as inhibitor of HMG-CoA reductase and modulator of plasma and hepatic lipids in high cholesterol-fed rats
  560. Naringenin 7-O-methyltransferase involved in the biosynthesis of the flavanone phytoalexin sakuranetin from rice (Oryza sativa L.)
  561. Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade
  562. Naringenin adds to the protective effect of l-arginine in monocrotaline-induced pulmonary hypertension in rats: Favorable modulation of oxidative stress, inflammation …
  563. Naringenin alleviates cadmium-induced toxicity through the abrogation of oxidative stress in Swiss albino mice
  564. Naringenin alleviates high D-glucose-induced injuries through upregulation of microRNA-30d-5p level in human AC16 cardiac cells
  565. Naringenin ameliorated kidney injury through Let-7a/TGFBR1 signaling in diabetic nephropathy
  566. Naringenin ameliorates acute inflammation by regulating intracellular cytokine degradation
  567. Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin …
  568. Naringenin Ameliorates Behavioral Dysfunction and Neurological Deficits in a d-Galactose-Induced Aging Mouse Model Through Activation of PI3K/Akt/Nrf2 Pathway
  569. Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation
  570. Naringenin ameliorates doxorubicin toxicity and hypoxic condition in Dalton’s lymphoma Ascites tumor mouse Model: Evidence from electron paramagnetic resonance …
  571. Naringenin Ameliorates Drosophila ReepA Hereditary Spastic Paraplegia-Linked Phenotypes
  572. Naringenin ameliorates hypoxia/reoxygenation-induced endoplasmic reticulum stress-mediated apoptosis in H9c2 myocardial cells: involvement in ATF6, IRE1α and …
  573. Naringenin ameliorates inflammation and cell proliferation in benzo (a) pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA …
  574. Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver
  575. Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy
  576. Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat
  577. Naringenin ameliorates LPS‑induced acute lung injury through its anti‑oxidative and anti‑inflammatory activity and by inhibition of the PI3K/AKT pathway
  578. Naringenin ameliorates pathological changes in liver and kidney of diabetic mice: a preliminary study/Naringenin reducira histopatološke promjene u jetri i …
  579. Naringenin ameliorates progression of endometriosis by modulating Nrf2/Keap1/HO1 axis and inducing apoptosis in rats
  580. Naringenin ameliorates radiation-induced lung injury by lowering IL-1β level
  581. Naringenin ameliorates renal and platelet purinergic signalling alterations in high-cholesterol fed rats through the suppression of ROS and NF-κB signaling pathways
  582. Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats
  583. Naringenin ameliorates skin inflammation and accelerates phenotypic reprogramming from M1 to M2 macrophage polarization in atopic dermatitis NC/Nga mouse …
  584. Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with …
  585. Naringenin and 17β‐estradiol coadministration prevents hormone‐induced human cancer cell growth
  586. Naringenin and atherosclerosis: a review of literature
  587. Naringenin and falcarinol stimulate glucose uptake and TBC1D1 phosphorylation in porcine myotube cultures
  588. Naringenin and hesperetin induce growth arrest, apoptosis, and cytoplasmic fat deposit in human preadipocytes
  589. Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up‐regulate transcription of adiponectin
  590. Naringenin and interindividual variability in interaction of coumarin with grapefruit juice
  591. Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective
  592. Naringenin and its nanocarriers as potential phytotherapy for autism spectrum disorders
  593. Naringenin and neopocirin from Micromeria species and Calamintha nepeta.
  594. Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model
  595. Naringenin and quercetin–potential anti-HCV agents for NS2 protease targets
  596. Naringenin and the liver
  597. Naringenin application alters function and metabolism of pea nodules
  598. Naringenin as a novel inhibitor of Two-Pore Channel 2 controlling the angiogenic process in vitroand in vivo
  599. Naringenin as a potential immunomodulator in therapeutics
  600. Naringenin as an opener of mitochondrial potassium channels in dermal fibroblasts
  601. Naringenin Attenuated Prostate Cancer Invasion via Reversal of Epithelial–to–Mesenchymal Transition and Inhibited uPA Activity
  602. Naringenin attenuates behavioral derangements induced by social defeat stress in mice via inhibition of acetylcholinesterase activity, oxidative stress and …
  603. Naringenin attenuates carotid restenosis in rats after balloon injury through its anti-inflammation and anti-oxidative effects via the RIP1-RIP3-MLKL signaling pathway
  604. Naringenin attenuates CCl4‐induced hepatic inflammation by the activation of an Nrf2‐mediated pathway in rats
  605. Naringenin attenuates cisplatin nephrotoxicity in rats
  606. Naringenin attenuates fibroblast activation and inflammatory response in a mechanical stretch-induced hypertrophic scar mouse model
  607. Naringenin Attenuates H2O2-Induced Mitochondrial Dysfunction by an Nrf2-Dependent Mechanism in SH-SY5Y Cells
  608. Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
  609. Naringenin attenuates highly active antiretroviral therapy‐induced sperm DNA fragmentations and testicular toxicity in Sprague‐Dawley rats
  610. Naringenin attenuates inflammation in chronic obstructive pulmonary disease in cigarette smoke induced mouse model and involves suppression of NF-κB.
  611. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase …
  612. Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies
  613. Naringenin attenuates nonalocholic fatty liver disease by downregulating NLRP3/NF‐κB pathway in mice
  614. Naringenin attenuates pressure overload-induced cardiac hypertrophy
  615. Naringenin attenuates testicular damage, germ cell death and oxidative stress in streptozotocin induced diabetic rats: Naringenin prevents diabetic rat testicular …
  616. Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways
  617. Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting …
  618. Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells
  619. Naringenin chalcone improves adipocyte functions by enhancing adiponectin production
  620. Naringenin chalcone suppresses allergic asthma by inhibiting the type-2 function of CD4 T cells
  621. Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects
  622. Naringenin complexed with hydroxypropyl-β-cyclodextrin improves the sciatic nerve regeneration through inhibition of p75NTR and JNK pathway
  623. Naringenin complexes with copper ions: potentiometric studies.
  624. Naringenin confers cardioprotection against ischemia-reperfusion injury in aged rats
  625. Naringenin confers protection against oxidative stress through upregulation of Nrf2 target genes in cardiomyoblast cells
  626. Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells
  627. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat–fed low-density lipoprotein receptor–null mice
  628. Naringenin decreases α-synuclein expression and neuroinflammation in MPTP-induced Parkinson’s disease model in mice
  629. Naringenin degradation by the endophytic diazotroph Herbaspirillum seropedicae SmR1
  630. Naringenin derivative diethyl (5, 4′-dihydroxy flavanone-7-yl) phosphate inhibits cell growth and induces apoptosis in A549 human lung cancer cells
  631. Naringenin derivatives as anti-atherogenic agents
  632. Naringenin diglucoside and other constituents from Citrus paradisi Macf.
  633. Naringenin encapsulation in β-CD and in heptakis(2,6-di-O-methyl)-β-CD:NMR, NBO and QTAIM analysis
  634. Naringenin enhanced efficiency of GUS activity in Passiflora mollissima (HBK) Bailey
  635. Naringenin enhanced efficiency ofRhizobium meliloti-alfalfa symbiosis
  636. Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome
  637. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in C aco‐2 cells
  638. Naringenin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt’s lymphoma cells
  639. Naringenin enhances the anti-tumor effect of doxorubicin on HeLa cervical cancer cells through cytotoxic activity and apoptosis induction
  640. Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein
  641. Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation
  642. Naringenin enhances the efficacy of human embryonic stem cell-derived pancreatic endoderm in treating gestational diabetes mellitus mice
  643. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr−/− mice
  644. Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of ERRα/VEGF/KDR signaling pathway
  645. Naringenin exerts anti-inflammatory effects in paraquat-treated SH-SY5Y cells through a mechanism associated with the Nrf2/HO-1 axis
  646. Naringenin Exerts Cardiovascular Protective Effect in a Palmitate‐Induced Human Umbilical Vein Endothelial Cell Injury Model via Autophagy Flux Improvement
  647. Naringenin exerts cytoprotective effect against paraquat-induced toxicity in human bronchial epithelial BEAS-2B cells through NRF2 activation
  648. Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice
  649. Naringenin eye drops inhibit corneal neovascularization by anti-inflammatory and antioxidant mechanisms
  650. Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia
  651. Naringenin from cooked tomato paste is bioavailable in men
  652. Naringenin glucuronidation in liver and intestine microsomes of humans, monkeys, rats, and mice
  653. Naringenin has a chemoprotective effect in MDA‑MB‑231 breast cancer cells via inhibition of caspase‑3 and‑9 activities
  654. Naringenin has anti‐inflammatory properties in macrophage and ex vivo human whole‐blood models
  655. Naringenin impairs two-pore channel 2 activity and inhibits VEGF-induced angiogenesis
  656. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner
  657. Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK
  658. Naringenin improves learning and memory in an Alzheimer’s disease rat model: Insights into the underlying mechanisms
  659. Naringenin improves mitochondrial function and reduces cardiac damage following ischemia-reperfusion injury: the role of the AMPK-SIRT3 signaling pathway
  660. Naringenin improves mitochondrial function and reduces cardiac damage following ischemia-reperfusion injury: the role of the AMPK-SIRT3 signaling pathway
  661. Naringenin improves the healing process of thermally-induced skin damage in rats
  662. Naringenin improves the sunscreen performance of vegetable nanocarriers
  663. Naringenin in combination with vitamins C and E potentially protects oxidative stress-mediated hepatic injury in cadmium-intoxicated rats
  664. Naringenin in the organic solvent extraction and separation attempt [J]
  665. Naringenin Increases Insulin Sensitivity and Metabolic Rate: A Case Study
  666. Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells
  667. Naringenin induces laxative effects by upregulating the expression levels of c-Kit and SCF, as well as those of aquaporin 3 in mice with loperamide-induced …
  668. Naringenin induces mitochondria-mediated apoptosis and endoplasmic reticulum stress by regulating MAPK and AKT signal transduction pathways in endometriosis …
  669. Naringenin Induces the nodABC Promotor of Rhizobium Leguminosarum as Well as Tsr Factor Production
  670. Naringenin Inhibit the Hydrogen Peroxide-Induced SH-SY5Y Cells Injury Through Nrf2/HO-1 Pathway
  671. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms
  672. Naringenin inhibition on expiants in vitro ofCichorium intybus (Chicory)
  673. Naringenin inhibits adipogenesis and reduces insulin sensitivity and adiponectin expression in adipocytes
  674. Naringenin inhibits alcoholic injury by improving lipid metabolism and reducing apoptosis in zebrafish larvae
  675. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-κB activity in a murine model of asthma
  676. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-κB activity in a murine model of asthma.
  677. Naringenin inhibits allergen‑induced airway remodeling in a murine model of asthma
  678. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat …
  679. Naringenin inhibits cell growth and migration in human breast cancer cell lines
  680. Naringenin inhibits dendritic cell maturation and has therapeutic effects in a murine model of collagen-induced arthritis
  681. Naringenin Inhibits Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats
  682. Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation
  683. Naringenin inhibits human osteoclastogenesis and osteoclastic bone resorption
  684. Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP‑2
  685. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways
  686. Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and-9
  687. Naringenin inhibits neointimal hyperplasia following arterial reconstruction with interpositional vein graft
  688. Naringenin inhibits NG‑nitro‑L‑arginine methyl ester‑induced hypertensive left ventricular hypertrophy by decreasing angiotensin‑converting enzyme 1 …
  689. Naringenin inhibits osteoclastogenesis through modulation of helper T cells‐secreted IL‐4
  690. Naringenin inhibits pacemaking activity in interstitial cells of Cajal from murine small intestine
  691. Naringenin inhibits phosphoinositide 3-kinase activity and glucose uptake in 3T3-L1 adipocytes
  692. Naringenin inhibits progression, proliferation and induces apoptosis via ROS generation in endometriotic lesions in rats
  693. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway
  694. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels
  695. Naringenin inhibits seed germination and seedling root growth through a salicylic acid-independent mechanism in Arabidopsis thaliana
  696. Naringenin Inhibits Skeletal Muscle Fibrosis after Acute Contusion in a Mouse Model
  697. Naringenin inhibits spinal cord injury-induced activation of neutrophils through miR-223
  698. Naringenin inhibits superoxide anion-induced inflammatory pain: role of oxidative stress, cytokines, Nrf-2 and the NO− cGMP− PKG− KATPChannel signaling …
  699. Naringenin inhibits the aggregation of expanded polyglutamine tract-containing protein through the induction of endoplasmic reticulum chaperone GRP78
  700. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism
  701. Naringenin inhibits the growth and stimulates the lignification of soybean root
  702. Naringenin inhibits the growth of Dictyostelium and MDCK‐derived cysts in a TRPP2 (polycystin‐2)‐dependent manner
  703. Naringenin inhibits the upregulation of CYP 3A4 and attenuates the cellular toxicity induced by rifampicin and isoniazid in hepatocytes
  704. Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1
  705. Naringenin inhibits transforming growth factor‑β1‑induced cardiac fibroblast proliferation and collagen synthesis via G0/G1 arrest
  706. Naringenin inhibits UVB irradiation-induced inflammation and oxidative stress in the skin of hairless mice
  707. Naringenin inhibits vascular smooth muscle cell function involving reactive oxygen species production modulation and NF-κB activity suppression
  708. Naringenin inhibits α-glucosidase activity: A promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats
  709. Naringenin interferes with the anti-diabetic actions of pioglitazone via pharmacodynamic interactions
  710. Naringenin is a novel inhibitor of Dictyostelium cell proliferation and cell migration
  711. Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro study
  712. Naringenin is an inhibitor of T cell effector functions
  713. Naringenin may block RSV-induced mucous hypersecretion in A549 cell via JNK/AP-1 signaling pathway
  714. Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats
  715. Naringenin mitigates iron-induced anxiety-like behavioral impairment, mitochondrial dysfunctions, ectonucleotidases and acetylcholinesterase alteration activities in …
  716. Naringenin mitigates titanium dioxide (TiO2)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NFκB
  717. Naringenin modifies the development of lineage-specific effector CD4+ T cells
  718. Naringenin modulates circulatory lipid peroxidation, anti‐oxidant status and hepatic alcohol metabolizing enzymes in rats with ethanol induced liver injury
  719. Naringenin modulates intracellular signaling pathways and cell surface receptors in Chlamydia trachomatis-infected mouse J774 macrophages to control …
  720. Naringenin modulates skeletal muscle differentiation via estrogen receptor α and β signal pathway regulation
  721. Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases-2/-9 via ROS/ERK1/2 pathways
  722. Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia
  723. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy
  724. Naringenin palliates cisplatin and doxorubicin gonadal toxicity in male rats
  725. Naringenin potentiated β-sitosterol healing effect on the scratch wound assay
  726. Naringenin pre-treatment inhibits neuroapoptosis and ameliorates cognitive impairment in rats exposed to isoflurane anesthesia by regulating the PI3/Akt …
  727. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr−/− mice
  728. Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats
  729. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor–null mice with diet-induced insulin resistance
  730. Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
  731. Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases
  732. Naringenin prevents ischaemic stroke damage via anti‐apoptotic and anti‐oxidant effects
  733. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21
  734. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation
  735. Naringenin produces neuroprotection against LPS-induced dopamine neurotoxicity via the inhibition of microglial NLRP3 inflammasome activation
  736. Naringenin promote apoptosis in cerebrally implanted C6 glioma cells
  737. Naringenin promotes microglial M2 polarization and Aβ degradation enzyme expression
  738. Naringenin promotes recovery from colonic damage through suppression of epithelial TNF-α production and induction of M2-type macrophages in colitic mice
  739. Naringenin promotes recovery from colonic damage through suppression of epithelial tumor necrosis factor–α production and induction of M2-type macrophages in …
  740. Naringenin promotes thermogenic gene expression in human white adipose tissue
  741. Naringenin protects against 1-methyl-4-phenylpyridinium-induced neuroinflammation and resulting reactive oxygen species production in SH-SY5Y cell line …
  742. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway
  743. Naringenin protects against acute pancreatitis in two experimental models in mice by NLRP3 and Nrf2/HO-1 pathways
  744. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats
  745. Naringenin protects against isoniazid-and rifampicin-induced apoptosis in hepatic injury
  746. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression
  747. Naringenin protects against scopolamine-induced dementia in rats
  748. Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress.
  749. Naringenin protects cardiac hypercholesterolemia-induced oxidative stress and subsequent necroptosis in rats
  750. Naringenin Protects HaCaT Human Keratinocytes Against UVB‐induced Apoptosis and Enhances the Removal of Cyclobutane Pyrimidine Dimers from the Genome†
  751. Naringenin protects human keratinocytes against UVB-induced damage: Role of cellular apoptosis and DNA repair
  752. Naringenin protects keratinocytes from oxidative stress injury via inhibition of the NOD2-mediated NF-κB pathway in pemphigus vulgaris
  753. Naringenin protects motor neuron against methylglyoxal-induced neurotoxicity through activatinG IGF-1R-related neuroprotection
  754. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway
  755. Naringenin reduces inflammatory pain in mice
  756. Naringenin reduces lung metastasis in a breast cancer resection model
  757. Naringenin reduces oxidative stress and improves mitochondrial dysfunction via activation of the Nrf2/ARE signaling pathway in neurons
  758. Naringenin reduces tumor size and weight lost in N-methyl-N′-nitro-N-nitrosoguanidine–induced gastric carcinogenesis in rats
  759. Naringenin regulates CFTR activation and expression in airway epithelial cells
  760. Naringenin regulates expression of genes involved in cell wall synthesis in Herbaspirillum seropedicae
  761. Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat …
  762. Naringenin Schiff base: antioxidant activity, acid–base profile, and interactions with DNA
  763. Naringenin stimulates cholecystokinin secretion in STC-1 cells
  764. Naringenin Supplementation of a Low-Fat Diet Enhances the Reversal of Metabolic Dysfunction, Promotes Atherosclerosis Regression and Improves Lesion …
  765. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Ldlr-/-Mice with Isocaloric Food Intake
  766. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair‐Fed Ldlr−/− Mice
  767. Naringenin Supplementation to a Chow Diet Reduces Plasma Lipids and Adiposity, and Suppresses Rer In Ldlr-/- Mice Fed a Chow Diet
  768. Naringenin Suppresses Chemically Induced Skin Cancer in Two-Stage Skin Carcinogenesis Mouse Model
  769. Naringenin suppresses Edwardsiella tarda infection in GAKS cells by NanA sialidase inhibition
  770. Naringenin suppresses growth of human placental choriocarcinoma via reactive oxygen species-mediated P38 and JNK MAPK pathways
  771. Naringenin suppresses K562 human leukemia cell proliferation and ameliorates Adriamycin-induced oxidative damage in polymorphonuclear leukocytes
  772. Naringenin suppresses macrophage infiltration into adipose tissue in an early phase of high-fat diet-induced obesity
  773. Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression
  774. Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells
  775. Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells
  776. Naringenin targets ERK 2 and suppresses UVB‐induced photoaging
  777. Naringenin targets on astroglial Nrf2 to support dopaminergic neurons
  778. Naringenin up‐regulates the expression of death receptor 5 and enhances TRAIL‐induced apoptosis in human lung cancer A549 cells
  779. Naringenin– and Funneliformis mosseae-Mediated Alterations in Redox State Synchronize Antioxidant Network to Alleviate Oxidative Stress in Cicer arietinum L …
  780. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes
  781. Naringenin-chalcone synthase
  782. Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells
  783. Naringenin-induced apoptosis via activation of NF-κB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells
  784. Naringenin-induced enhanced antioxidant defence system meliorates cholinergic neurotransmission and consolidates memory in male rats
  785. Naringenin-induced exoproteome of Rhizobium etli CE3
  786. Naringenin-induced HO-1 ameliorates high glucose or free fatty acids-associated apoptosis via PI3K and JNK/Nrf2 pathways in human umbilical vein endothelial cells
  787. Naringenin-induced migration of embrynoic trophectoderm cells is mediated via PI3K/AKT and ERK1/2 MAPK signaling cascades
  788. Naringenin-LOADED CHITOSAN NANOPARTICLES FORMULATION, AND ITS IN VITRO EVALUATION AGAINST T47D BREAST CANCER CELL LINE
  789. Naringenin-loaded nano-structured lipid carrier fortifies oxaliplatin-dependent apoptosis in HT-29 cell line
  790. Naringenin-Loaded Nanoparticles Improve the Physicochemical Properties and the Hepatoprotective Effects of Naringenin in Orally-Administered Rats with CCl4 …
  791. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics
  792. Naringenin-Loaded TPGS Polymeric Nanosuspension: In-Vitro and In-Vivo Anti-Inflammatory Activity
  793. Naringenin-mediated ATF3 expression contributes to apoptosis in human colon cancer
  794. Naringenin-type flavonoids show different estrogenic effects in mammalian and teleost test systems
  795. Naringenin‐Induced Apoptotic Cell Death in Prostate Cancer Cells Is Mediated via the PI3K/AKT and MAPK Signaling Pathways
  796. Naringenin‐responsive riboswitch‐based fluorescent biosensor module for Escherichia coli co‐cultures
  797. Naringenin, a citrus flavanone, enhances isoproterenol-stimulated thermogenic activation of 3T3-L1 adipocytes
  798. Naringenin, a citrus flavonoid, ameliorates arsenic-induced toxicity in Swiss albino mice
  799. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK
  800. Naringenin, a common flavanone, inhibits the formation of AGEs in bread and attenuates AGEs-induced oxidative stress and inflammation in RAW264. 7 cells
  801. Naringenin, a dietary flavanone, enhances insulin-like growth factor 1 receptor-mediated antioxidant defense and attenuates methylglyoxal-induced neurite damage …
  802. Naringenin, a flavanone alters the tumorigenic features of C6 glioma cells
  803. Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats
  804. Naringenin, a major bioactive lead of Thymus vulgaris, inhibits growth, induces apoptosis and modulates cell cycle and apoptosis-regulatory gene expression in …
  805. Naringenin; a bioflavonoid, impairs the reproductive potential of male mice
  806. Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells
  807. Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis
  808. Naringenin: A Promising Flavonoid for Herbal Treatment of Rheumatoid Arthritis and Associated Inflammatory Disorders
  809. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity
  810. Naringenin: an analgesic and anti-inflammatory citrus flavanone
  811. Naringenin: an immunomodulator of Interleukin (IL)-6, IL-8, and Tumor Necrosis Factor secretion from Chlamydia trachomatis-infected macrophages and epithelial …
  812. Naringin and Naringenin are not the primary CYP3A inhibitors in grapefruit juice
  813. Naringin and Naringenin determination and control in grapefruit juice by a validated HPLC method
  814. Naringin and Naringenin inhibit nitrite-induced methemoglobin formation
  815. Naringin and Naringenin Relax Rat Tracheal Smooth by Regulating BKCa Activation
  816. Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and Naringenin: Systematic approach for improved breast cancer …
  817. Natural variation in the expression and catalytic activity of a Naringenin 7‐O‐methyltransferase influences antifungal defenses in diverse rice cultivars
  818. Navel orange peel hydroethanolic extract, naringin and Naringenin have anti-diabetic potentials in type 2 diabetic rats
  819. Negative regulation of β-catenin/Tcf signaling by Naringenin in AGS gastric cancer cell
  820. Neuroprotective effect of Naringenin against MPTP-induced oxidative stress
  821. Neuroprotective effect of Naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke
  822. Neuroprotective properties of the natural phenolic antioxidants curcumin and Naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease
  823. Neuroprotective role of Naringenin against methylmercury induced cognitive impairment and mitochondrial damage in a mouse model
  824. Neuroprotective role of Naringenin on carbaryl induced neurotoxicity in mouse neuroblastoma cells
  825. Non-empirical assignment of the absolute configuration of (−)-Naringenin, by coupling the exciton analysis of the circular dichroism spectrum and the ab initio …
  826. Non-empirical assignment of the absolute configuration of-Naringenin, by coupling the exciton analysis of the circular dichroism spectrum and the ab initio calculation …
  827. Novel O-alkyl derivatives of Naringenin and their oximes with antimicrobial and anticancer activity
  828. Ocular pharmacokinetics of Naringenin eye drops following topical administration to rabbits
  829. On the ability of four flavonoids, baicilein, luteolin, Naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex
  830. On the neuroprotective effects of Naringenin: Pharmacological targets, signaling pathways, molecular mechanisms, and clinical perspective
  831. Optimization of Naringenin and p‐coumaric acid hydroxylation using the native E. coli hydroxylase complex, HpaBC
  832. Oral Naringenin nanocarriers: Fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments
  833. Oxidation of Naringenin by gamma-radiation
  834. Participation of antioxidant and cholinergic system in protective effect of Naringenin against type-2 diabetes-induced memory dysfunction in rats
  835. Partition and digestive stability of α-tocopherol and resveratrol/Naringenin in whey protein isolate emulsions
  836. Peroxidative metabolism of apigenin and Naringenin versus luteolin and quercetin: glutathione oxidation and conjugation
  837. Pharmaceutical cocrystals of Naringenin with improved dissolution performance
  838. Pharmacokinetic and tissue distributions of Naringenin and Naringenin Nanosuspension
  839. Pharmacokinetic interaction study between flavanones (hesperetin, Naringenin) and rasagiline mesylate in wistar rats
  840. Pharmacokinetic study of the prokinetic ABCs liquiritigenin, Naringenin and hesperitin following the oral administration of Si–Ni–San decoction to functional dyspepsia …
  841. Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling of Effect of Naringenin and Its Surface Modified Nanocarriers on Associated and Core Behaviors of …
  842. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update
  843. Pharmacokinetics and conjugation metabolism of naringin and Naringenin in rats after single dose and multiple dose administrations
  844. Pharmacokinetics of hesperetin and Naringenin in the Zhi Zhu Wan, a traditional Chinese medicinal formulae, and its pharmacodynamics study
  845. Pharmacokinetics of Naringin and its Metabolite Naringenin in Rats after Oral Administration of Rhizoma Drynariae Extract Assayed by UPLC-MS/MS
  846. Pharmacokinetics of naringin and its metabolite Naringenin in rats after oral administration of Rhizoma Drynariae extract assayed by UPLC-MS/MS.
  847. Pharmacokinetics of selected chiral flavonoids: hesperetin, Naringenin and eriodictyol in rats and their content in fruit juices
  848. Pharmacokinetics of the citrus flavanone aglycones hesperetin and Naringenin after single oral administration in human subjects
  849. Pharmacological properties and therapeutic potential of Naringenin: a citrus flavonoid of pharmaceutical promise
  850. Photoelectron spectroscopy of natural products: Hydroxy-flavones and Naringenin
  851. Photoprotective and Antigenotoxic Effects of the Flavonoids Apigenin, Naringenin and Pinocembrin
  852. Physical mixture interaction of acetaminophenol with Naringenin
  853. Physical properties and biological activities of hesperetin and Naringenin in complex with methylated β-cyclodextrin
  854. Phytoalexin production by amino acid conjugates of jasmonic acid through induction of Naringenin‐7‐O‐methyltransferase, a key enzyme on phytoalexin biosynthesis …
  855. Plasma concentrations of the flavonoids hesperetin, Naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit …
  856. Plasma kinetics and urinary excretion of the flavanones Naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice
  857. Plausible role of Naringenin against cerebrally implanted C6 glioma cells in rats
  858. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia
  859. Positive effects of Naringenin on near-surface membrane fluidity in human erythrocytes
  860. Positive effects of Naringenin on near-surface membrane fluidity in human erythrocytes
  861. Possible regulation of LDL-receptor by Naringenin in HepG2 hepatoma cell line
  862. Potential beneficial effect of Naringenin on lipid peroxidation and antioxidant status in rats with ethanol‐induced hepatotoxicity
  863. Potential of cationic-polymeric nanoparticles for oral delivery of Naringenin: in vitro and in vivo investigations
  864. Potential protective effects of Naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats
  865. Practical synthesis of Naringenin
  866. Preliminary Investigation of Naringenin Hydroxylation with Recombinant E. coli Expressing Plant Flavonoid Hydroxylation Gene
  867. Prenylation has a compound specific effect on the estrogenicity of Naringenin and genistein
  868. Preparation and characterization of cyclodextrin inclusion complex of Naringenin and critical comparison with phospholipid complexation for improving solubility and …
  869. Preparation and characterization of inclusion complexes of Naringenin with β-cyclodextrin or its derivative
  870. Preparation and characterization of Naringenin microparticles via a supercritical anti-solvent process
  871. Preparation and characterization of Naringenin-loaded elastic liposomes for topical application
  872. Preparation and characterization of phospholipid complexes of Naringenin for effective drug delivery
  873. Preparation and drug-release in vitro of Naringenin liposomes
  874. Preparation and evaluation of Naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery
  875. Preparation and evaluation of submicron-carriers for Naringenin topical application
  876. Preparation and in vitro release of buccal tablets of Naringenin-loaded MPEG-PCL nanoparticles
  877. Preparation and pharmacodynamic evaluation of Naringenin lyophilized liposome.
  878. Preparation and physicochemical properties of the complex of Naringenin with hydroxypropyl-β-cyclodextrin
  879. Preparation of Naringenin by enzymolysis of naringin-HP-beta-CD
  880. Preparation of Naringenin-PVPK-30 solid dispersion and its characteristics in vitro [J]
  881. Preparation of Naringenin/β-cyclodextrin complex and its more potent alleviative effect on choroidal neovascularization in rats
  882. Preparation, Characterization and Evaluation In Vitro of Naringenin-PVP K-30 Solid Dispersions
  883. Preparations and release characteristics of naringin and Naringenin gastro-resistant microparticles by spray-drying
  884. PREVENTIVE EFFECTS OF Naringenin (CITRUS FLAVONONE) ON INTESTINAL ISCHEMIA–REPERFUSION INJURY IN THE RAT
  885. Production of genistein from Naringenin using Escherichia coli containing isoflavone synthase-cytochrome P450 reductase fusion protein
  886. Production of Naringenin from D‐xylose with co‐culture of E. coli and S. cerevisiae
  887. Proliferative effects of the phytoestrogens 8-PrenylNaringenin, 6-(1.1-dimethylallyl) Naringenin and Naringenin in MCF-7 cells and the rat mammary gland
  888. Promotion of mitochondrial protection by Naringenin in methylglyoxal-treated SH-SY5Y cells: Involvement of the Nrf2/GSH axis
  889. Prooxidant activities of different doses of Naringenin and its regulatory effect on the growth of nasopharyn-geal carcinoma CNE2 cells
  890. Protection against doxorubicin-induced oxidative damage in normal blood cells by Naringenin
  891. Protection of Radiation induced Somatic Damage by the Reduction of Oxidative Stress at Critical Organs of Rat with Naringenin Administration
  892. Protective effect of hesperetin and Naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats
  893. Protective effect of Naringenin against acetaminophen-induced acute liver injury in metallothionein (MT)-null mice
  894. Protective effect of Naringenin against Arsenic trioxide induced oxidative stress
  895. Protective effect of Naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling
  896. Protective effect of Naringenin against gentamicin-induced nephrotoxicity in rats
  897. Protective effect of Naringenin against isoniazid-induced adverse reactions in rats
  898. Protective effect of Naringenin against lead-induced oxidative stress in rats
  899. Protective effect of Naringenin against lipopolysaccharide-induced acute lung injury in rats
  900. Protective effect of Naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling
  901. Protective effect of Naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression
  902. Protective effect of Naringenin on acetic acid-induced ulcerative colitis in rats
  903. Protective effect of Naringenin on focal cerebral ischemia reperfusion injury in rats [J]
  904. Protective effect of Naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells
  905. Protective effect of Naringenin on hepatic and renal dysfunction and oxidative stress in arsenic intoxicated rats
  906. Protective effect of Naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes
  907. Protective effects of Naringenin against hypoxic-ischemic brain damage in neonatal rats through suppression of NOD2/RIP2/NF-κB pathway
  908. Protective effects of Naringenin eye drops on N-methyl-N-nitrosourea-induced photoreceptor cell death in rats
  909. Protective Effects of Naringenin in a Rat Model of Sepsis-Triggered Acute Kidney Injury via Activation of Antioxidant Enzymes and Reduction in Urinary …
  910. Protective effects of Naringenin in cardiorenal syndrome
  911. Protective effects of Naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney
  912. Protective effects of Naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress
  913. Protective effects of Naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells
  914. Protective Role Of Naringenin Against Aβ25-35-Caused Damage via ER and PI3K/Akt-Mediated Pathways
  915. Protective role of Naringenin against doxorubicin-induced cardiotoxicity in a rat model: histopathology and mRNA expression profile studies
  916. Protective role of Naringenin on circadian rhythms of liver marker enzymes during N-nitrosodiethylamine induced hepatocarcinogenesis in rats
  917. Prunin identification, biological activity and quantitative change in comparison to Naringenin in dormant peach buds
  918. Purification and identification of Naringenin 7-O-methyltransferase, a key enzyme in biosynthesis of flavonoid phytoalexin sakuranetin in rice
  919. PVP-coated Naringenin nanoparticles for biomedical applications–In vivo toxicological evaluations
  920. Qualitative changes in proteins contained in outer membrane vesicles produced by Rhizobium etli grown in the presence of the nod gene inducer Naringenin
  921. Quantification of Naringenin encapsulated in solid lipid nanoparticles by validated UV-spectroscopy method
  922. Quantitative analysis of rutin, quercetin, Naringenin, and gallic acid by validated RP-and NP-HPTLC methods for quality control of anti-HBV active extract of Guiera …
  923. Quantitative analysis of the Naringenin‐inducible proteome in Rhizobium leguminosarum by isobaric tagging and mass spectrometry
  924. Quantitative effect of the expression level of key genes in Naringenin synthesis on the accumulation level of target products
  925. Quercetin and Naringenin abate diethylnitrosamine/acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: the roles of oxidative stress, inflammation and …
  926. Quercetin and Naringenin reduce abnormal development of mouse embryos produced by hydroxyurea
  927. Quercetin and Naringenin transport across human intestinal Caco‐2 cells
  928. Quercetin and Naringenin; effects on ulcer formation and gastric secretion in rats
  929. Quick development of an analytical enantioselective high performance liquid chromatography separation and preparative scale-up for the flavonoid Naringenin
  930. Raman spectroscopic investigation of the chemopreventive response of Naringenin and its nanoparticles in DMBA-induced oral carcinogenesis
  931. Rapid quantitative analysis of Naringenin in the fruit bodies of Inonotus vaninii by two-phase acid hydrolysis followed by reversed phase-high performance …
  932. Regiospecific methylation of Naringenin to ponciretin by soybean O-methyltransferase expressed in Escherichia coli
  933. Regiospecific modifications of Naringenin for astragalin production in Escherichia coli
  934. Regulation of apoptosis by modified Naringenin derivatives in human colorectal carcinoma RKO cells
  935. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and Naringenin
  936. Regulation of inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 murine macrophage by 7-O-methyl-Naringenin
  937. Relation of apoptosis of K562 cells induced by Naringenin in vitro to enzyme activity changes of caspase-3 and caspase-8 and expression of FAS/FASL proteins
  938. Relation of Apoptosis of K562 Induced by Naringenin to Expression of PCNA and Enzyme Activity Changes of Caspase
  939. Relative bioavailability of the flavonoids quercetin, hesperetin and Naringenin given simultaneously through diet
  940. Relaxant effect of flavonoid Naringenin on contractile activity of rat colonic smooth muscle
  941. Renoprotective Effects of Naringenin and Olive Oil against Cyclosporine-Induced Nephrotoxicity in Rats
  942. Research Article Losartan and/or Naringenin Ameliorates Doxorubicin Induced Cardiac, Hepatic and Renal Toxicities in Rats
  943. Research for the Naringenin to strengthen the immune effects of hepatitis B vaccine
  944. RESEARCH Open Access The flavonoid, Naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice.
  945. Research Progress of Naringenin [J]
  946. Response Surface Methodology for Ultrasound-Assisted Extraction of Naringenin from Peach (Prunus persica) Leaves
  947. Rest-breaking effect of thiourea in relation to respiratory rate and Naringenin content of peach buds
  948. Review of the flavonoids quercetin, hesperetin, and Naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology
  949. ROLE OF Naringenin AND ITS DERIVATIVES IN ANTIMUTAGENICITY-A REVIEW
  950. Role of Naringenin and phosphatidylinositol 3-kinase/Protein kinase B (PI3K/PKB) signal transduction pathway in the airway inflammation [J]
  951. Role of Naringenin in protection against diabetic hyperalgesia and tactile allodynia in male Wistar rats
  952. Safety and pharmacokinetics of Naringenin: A randomized, controlled, single‐ascending‐dose clinical trial
  953. Safety evaluation of Naringenin upon experimental exposure on rat gastrointestinal epithelium for novel optimal drug delivery
  954. Screening of chemopreventive effect of Naringenin-loaded nanoparticles in DMBA-induced hamster buccal pouch carcinogenesis by FT-IR spectroscopy
  955. Secretion of hepatocyte apoB is inhibited by the flavonoids, Naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP
  956. Selection and Optimization of Agar Confectionary Matrix for the Delivery of Naringenin from Grapefruit or Tomato Fruit Powders
  957. Selective growth suppression of five annual plant species by chalcone and Naringenin correlates with the total amount of 4‐coumarate: coenzyme A ligase
  958. Selective synthesis of citrus flavonoids prunin and Naringenin using heterogeneized biocatalyst on graphene oxide
  959. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo …
  960. Separation of the enantiomers of Naringenin and eriodictyol by amylose-based chiral reversed-phase high-performance liquid chromatography
  961. Sesamol and Naringenin reverse the effect of rotenone-induced PD rat model
  962. Silymarin and Naringenin protects nicotine induced oxidative stress in young rats
  963. Simultaneous analysis of quercetin and Naringenin in rat plasma by liquid chromatography–tandem mass spectrometry: application to a pharmacokinetic study after …
  964. Simultaneous Chiral Separation of Flavanone, Naringenin, and Hesperetin Enantiomers by RP‐UHPLC‐DAD
  965. Simultaneous determination of linarin, Naringenin and formononetin in rat plasma by LC‐MS/MS and its application to a pharmacokinetic study after oral …
  966. Simultaneous determination of Naringenin and hesperetin in rats after oral administration of Da‐Cheng‐Qi decoction by high‐performance liquid chromatography …
  967. Simultaneous determination of naringin, hesperidin, neohesperidin, Naringenin and hesperetin of Fractus aurantii extract in rat plasma by liquid chromatography …
  968. Simultaneous determination of quercetin, rutin, naringin, and Naringenin in different fruits by capillary zone electrophoresis
  969. Simultaneous determination of rosuvastatin, naringin and Naringenin in rat plasma by RRLC–MS/MS and its application to a pharmacokinetic drug interaction study
  970. Simultaneous separation and sensitive detection of naringin and Naringenin in nanoparticles by chromatographic method indicating stability and photodegradation …
  971. Simultaneously Quantitative Analysis of Naringin and Its Major Human Gut Microbial Metabolites Naringenin and 3-(4′-Hydroxyphenyl) Propanoic Acid via Stable …
  972. Site-specific fluorescent labeling approaches for Naringenin, an essential flavonone in plant nitrogen-fixation signaling pathways
  973. Smad3 specific inhibitor, Naringenin, decreases the expression of extracellular matrix induced by TGF-β1 in cultured rat hepatic stellate cells
  974. Solubilities of naringin and Naringenin in different solvents and dissociation constants of Naringenin
  975. Solubility and preferential solvation of the flavonoid Naringenin in some aqueous/organic solvent mixtures
  976. Solubility of Naringenin in ethanol and water mixtures
  977. Solvatochromism of Naringenin in aqueous alcoholic mixtures
  978. Some Interactions of Gibberellic Acid with Naringenin (5, 7, 4′-trihydroxy flavanone) in the Control of Dormancy and Growth in Plants
  979. Sorption and interaction of the flavonoid Naringenin on tomato fruit cuticles
  980. Spectral analysis of Naringenin deprotonation in aqueous ethanol solutions
  981. Spectroscopic Studies on the Interaction of Naringenin, Apigenin with FTO
  982. Spermatogenesis induction of spermatogonial stem cells using nanofibrous poly(l‐lactic acid)/multi‐walled carbon nanotube scaffolds and Naringenin
  983. Spontaneous and enzymic rearrangement of Naringenin chalcone to flavanone
  984. Stabilization effects of Naringenin and caffeic acid on γ-irradiatedEPDM
  985. Stereospecific high-performance liquid chromatographic analysis of Naringenin in urine
  986. Stimulation of melanogenesis by the citrus flavonoid Naringenin in mouse B16 melanoma cells
  987. Stimulation of nitrogen fixation and trehalose biosynthesis by Naringenin (Nar) and arbuscular mycorrhiza (AM) in chickpea under salinity stress
  988. Structural Modification of the Flavanone Naringenin–Potential Impacts in Dietary Polyphenol Research
  989. Structure determination and in vitro/vivo study on carbamazepine-Naringenin (1: 1) cocrystal
  990. Structure of (R, S)-Naringenin
  991. Structure-related protein tyrosine phosphatase 1B inhibition by Naringenin derivatives
  992. StructureActivity Relationship of Plant Flavonoids Q uercetin Naringenin and Apigenin Associated with the Nodulation Gene Inducing Activities in Rhizobium …
  993. Studies on protective role of Naringenin on doxorubicin induced renal cardio and hepatotoxicities
  994. Studies on the constituents of Zizyphi fructus. V. Structures of glycosides of benzyl alcohol, vomifoliol and Naringenin
  995. STUDIES ON THE ROLE OF NRF2 ACTIVATOR Naringenin IN EXPERIMENTAL DIABETES
  996. Study of the neuropharmacological effects of Naringenin harmine and adenosine on parkinsonism induced in rats
  997. STUDY OF THE NEUROPHARMACOLOGICAL EFFECTS OF Naringenin, HARMINE AND ADENOSINE ON PARKINSONISM INDUCED IN RATS ThesisSTUDY OF …
  998. Study on Affinity of Naringenin with hPPARs and Its Intrinsic Activity
  999. Study on effect of Naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism
  1000. Study on intra-gastric floating beads of Naringenin
  1001. Study on Naringenin–CTMAB–DNA system by resonance light scattering technique and its analytical application
  1002. Study on protective effect of Naringenin (Citrus flavonone) on incipient diabetic hepatopathy in alloxan-induced diabetic rats
  1003. Study on the Preparation Method of Naringenin [J]
  1004. Substitution of positions 6 and 8 lead to an increased anti-androgenic activity of the phytoestrogen Naringenin
  1005. Substrate preference of citrus Naringenin rhamnosyltransferases and their application to flavonoid glycoside production in fission yeast
  1006. Sulfation of hesperetin, Naringenin and apigenin by the human cytosolic sulfotransferases: a comprehensive analysis
  1007. Sulfation of Naringenin by Cunninghamella elegans
  1008. Sulfation of Naringenin by Mucor sp
  1009. Sunscreen creams containing Naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations
  1010. Supplemental Naringenin prevents intestinal barrier defects and inflammation in colitic mice
  1011. Supplementation of Naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats
  1012. Supplementation with biscuits enriched with hesperidin and Naringenin is associated with an improvement of the Metabolic Syndrome induced by a cafeteria diet in …
  1013. Suppression of CYP1A1 expression by Naringenin in murine Hepa-1c1c7 cells
  1014. Suppression of early colon cancer lesions by apigenin and Naringenin is in part due to their downregulation of p21, TLR-4, and MCT-1 expression
  1015. Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by Naringenin in fructose-administered rats
  1016. Sustainable, Naringenin-Based Thermosets Show Reversible Macroscopic Shape Changes and Enable Modular Recycling
  1017. Switching on fluorescence for selective visual recognition of Naringenin and morin with a metal–organic coordination polymer of Zn (bix)[bix= 1, 4-bis (imidazol-1 …
  1018. Synergic effect of α-tocopherol and Naringenin in transglutaminase-induced differentiation of human prostate cancer cells
  1019. Synergistic effect of anti-human DR5 monoclonal antibody and Naringenin on human hepatocellular carcinoma HepG2 cells
  1020. Synthesis and anti-tumor activity of Naringenin derivatives
  1021. Synthesis and antiproliferative properties of novel Naringenin derivatives
  1022. Synthesis and biological activity of novel o-alkyl derivatives of Naringenin and their oximes
  1023. Synthesis and characterization of Naringenin-cobalt (Ⅱ) complex
  1024. Synthesis and characterization of Naringenin-copper (Ⅱ) complex
  1025. Synthesis and characterization of novel flavonoid-substituted phthalocyanines using (±) Naringenin
  1026. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives
  1027. Synthesis and Taste of Naringenin 7-0-(2-0-α-L-lyxopyranosyl-β-D-galactopyranoside) and Its Dihydrochalcone Derivative
  1028. Synthesis of flavonoid glycosides. Part XIII. Synthesis and taste of Naringenin 7-O-(2-O-. ALPHA.-L-lyxopyranosyl-. BETA.-D-galactopyranoside) and its …
  1029. Synthesis of nanoporous molecularly imprinted polymers for extraction of Naringenin compound
  1030. Synthesis of Naringenin amino acid esters as potential CDK2 inhibitors
  1031. SYNTHESIS OF RACEMIC 8-C-PRENYL-6″,6″-DIMETHYLPYRANO(2″, 3″:7,6)Naringenin
  1032. Synthesis, Cancer‐Selective Antiproliferative and Apoptotic Effects of Some (±)‐Naringenin Cycloaminoethyl Derivatives
  1033. Synthesis, characterization and antioxidant activity of Naringenin Schiff base and its Cu (II), Ni (II), Zn (II) complexes
  1034. Synthesis, characterization and antioxidant capacity of Naringenin-oxime
  1035. Synthesis, Characterization and Antioxidative Activities of the Naringenin Schiff‐Base and its Complexes with Some Rare Earth Elements
  1036. Synthesis, characterization and the antioxidative activity of copper (II), zinc (II) and nickel (II) complexes with Naringenin
  1037. Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth (III) complexes with Naringenin-2-hydroxy benzoyl hydrazone ligand
  1038. Synthesis, characterization, cytotoxic activities, and DNA-binding properties of the La (III) complex with Naringenin Schiff-base
  1039. Synthesis, cytotoxic activity, and DNA binding properties of copper (II) complexes with hesperetin, Naringenin, and apigenin
  1040. Synthesis, structural elucidation and antiradical activity of a copper (II) Naringenin complex
  1041. Tailoring Naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation
  1042. Targeting MAPK pathways by Naringenin modulates microglia M1/M2 polarization in lipopolysaccharide-stimulated cultures
  1043. Testicular microanatomical and hormonal alterations following use of antiretroviral therapy in Sprague Dawley rats: Role of Naringenin
  1044. Tetra-carboxy-methyl-Naringenin-chalcone, a new active to treat rosacea
  1045. The action of dietary phytochemicals quercetin, catechin, resveratrol and Naringenin on estrogen-mediated gene expression
  1046. The activation of mitochondrial BK potassium channels contributes to the protective effects of Naringenin against myocardial ischemia/reperfusion injury
  1047. The additive effects of the active component of grapefruit juice (Naringenin) and antiarrhythmic drugs on HERG inhibition
  1048. The ameliorative effect of Naringenin on paraquat-induced toxicity in mitochondria isolated from rats
  1049. The cardioprotective effect of Naringenin against ischemia–reperfusion injury through activation of ATP-sensitive potassium channel in rat
  1050. The caries reducing effect of Naringenin and of protamine in hamsters
  1051. The citrus flavanone Naringenin attenuates zymosan-induced mouse joint inflammation: induction of Nrf2 expression in recruited CD45+ hematopoietic cells
  1052. The citrus flavanone Naringenin impairs dengue virus replication in human cells
  1053. The citrus flavanone Naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury
  1054. The citrus flavanone Naringenin produces cardioprotective effects in hearts from 1 year old rat, through activation of mitoBK channels
  1055. The citrus flavanone Naringenin protects myocardial cells against age-associated damage
  1056. The citrus flavanone Naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
  1057. The citrus flavonoid Naringenin confers protection in a murine endotoxaemia model through AMPK-ATF3-dependent negative regulation of the TLR4 …
  1058. The citrus flavonoid Naringenin impairs the in vitro infection of human cells by Zika virus
  1059. The citrus flavonoid Naringenin stimulates DNA repair in prostate cancer cells
  1060. The Citrus Flavonoid, Naringenin Corrects the Dyslipidemia and Improves Insulin-Sensitivity in High-Fat Fed LDLR-/-Mice
  1061. The citrus flavonoids hesperetin and Naringenin block the lipolytic actions of TNF-α in mouse adipocytes
  1062. The citrus flavonone Naringenin reduces lipopolysaccharide-induced inflammatory pain and leukocyte recruitment by inhibiting NF-κB activation
  1063. The citrus fruit flavonoid Naringenin suppresses hepatic glucose production from Fao hepatoma cells
  1064. The citrus‐derived flavonoid Naringenin exerts uterotrophic effects in female mice at human relevant doses
  1065. The Different Effects of Resveratrol and Naringenin on Isolated Human Umbilical Vein: The Role of ATP‐Sensitive K+ Channels
  1066. The differential tissue distribution of the citrus flavanone Naringenin following gastric instillation
  1067. The effect of flavonoid Naringenin coupled with the developed biofilm Azorhizobium caulinodans-Aspergillus spp. on increase in rice yields in conventionally …
  1068. The effect of kaempferol and Naringenin may improve the in vitro quality of stored boar semen
  1069. The Effect of Naringenin and Antiarrhythmic Drugs on IKr Inhibition
  1070. The effect of Naringenin on oxidative stress in some tissues (heart, lung, brain, spleen, muscle) of lead-treated rats.
  1071. The effect of Naringenin on TGF-β1/Smad pathway in HBE cells
  1072. The effect of Naringenin on the fate and disposition of deoxynivalenol in piglets
  1073. The effect of Naringenin on the intestinal and renal transport of organic solutes
  1074. The effect of Naringenin on the pharmacokinetics of ibrutinib in rat: A drug–drug interaction study
  1075. The effect of Naringenin on the phosphorylation of AMPK in diet-induced obese mice
  1076. The effect of Naringenin on the role of nuclear factor (erythroid‐derived 2)‐like2 (Nrf2) and haem oxygenase 1 (HO‐1) in reducing the risk of oxidative stress‐related …
  1077. The effect of root exudate 7, 4′-dihydroxyflavone and Naringenin on soil bacterial community structure
  1078. The effects of dietary Naringenin supplementation on physiological changes in molar crestal alveolar bone–cemento-enamel junction distance in young rats
  1079. THE EFFECTS OF Naringenin ON HUMAN BREAST CANCER CELLS: A SYSTEMATIC REVIEW
  1080. The effects of Naringenin on some human breast cancer cells: A systematic review
  1081. The Effects of Naringenin on Volatile Formation, Browning Intensity and Antioxidant Capacity in Three Maillard Reaction Models
  1082. The effects of naringin and Naringenin on endotoxin-induced uveitis in rats
  1083. The efficacy of Naringenin in Poisoning Cases Remediation
  1084. The efficient total synthesis of bis-glycosyl apigenin from Naringenin: a greener way
  1085. The expectorant activity of Naringenin
  1086. The fate and toxicity of the flavonoids Naringenin and formononetin in soil
  1087. The flavanone Naringenin reduces the production of quorum sensing-controlled virulence factors in Pseudomonas aeruginosa PAO1
  1088. The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome
  1089. The flavonoid Naringenin enhances intercellular colonization of rice roots by Azorhizobium caulinodans
  1090. The flavonoid Naringenin inhibits dimethylnitrosamine-induced liver damage in rats
  1091. The flavonoid Naringenin stimulates the intercellular colonization of wheat roots by Azorhizobium caulinodans
  1092. The flavonoid, Naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
  1093. The Flavonoids Naringenin and Nobiletin Stimulate the AMPKinase Pathway in Primary Mouse Hepatocytes
  1094. The flavonone Naringenin inhibits chloride secretion in isolated colonic epithelia
  1095. The gastric anti-ulcer activity of Naringenin, a specific histidine decarboxylase inhibitor.
  1096. The grapefruit flavonoid Naringenin as a Hepatitis C virus therapy: efficacy, mechanism and delivery
  1097. The hop polyphenols xanthohumol and 8-prenyl-Naringenin antagonize the estrogenic effects of Fusarium mycotoxins in human endometrial cancer cells
  1098. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by Naringenin and attenuation of titanium-particle-induced …
  1099. The inhibitory effect of Naringenin on atopic dermatitis induced by DNFB in NC/Nga mice
  1100. The kinetics and mechanisms of the reactions of iron (III) with Naringenin, hesperetin, 3-hydroxychromone and 3-hydroxyflavone. A comparison of the coordination …
  1101. The Modification of the Flavonoid Naringenin by Bradyrhizobium sp. Strain ORS285 Changes the nod Genes Inducer Function to a Growth Stimulator
  1102. The Naringenin-induced exoproteome of Rhizobium etli CE3
  1103. The Naringenin‐induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background
  1104. The natural flavonoid Naringenin elicits analgesia through inhibition of NaV1. 8 voltage-gated sodium channels
  1105. The neuroprotective action of Naringenin on oseltamivir (Tamiflu) treated male rats
  1106. The Nrf2/HO-1 Axis as Targets for Flavanones: Neuroprotection by Pinocembrin, Naringenin, and Eriodictyol
  1107. The nutritional flavanone Naringenin triggers antiestrogenic effects by regulating estrogen receptor α-palmitoylation
  1108. The preventive effects and the mechanisms of action of navel orange peel hydroethanolic extract, naringin, and Naringenin in N-acetyl-p-aminophenol-induced liver …
  1109. The protective effect of Naringenin on airway remodeling after mycoplasma pneumoniae infection by inhibiting autophagy-mediated lung inflammation and fibrosis
  1110. The protective effect of Naringenin on oxaliplatin-induced genotoxicity in mice
  1111. The Protective Effect of Naringenin on Oxaliplatin-Induced Genotoxicity in Mice
  1112. The protective effect of Naringenin-oxime on cisplatin-induced toxicity in rats
  1113. The protective effects of Naringenin on testes gonadotoxicity induced by cisplatin in rats
  1114. The role of potassium channels in the vasodilatation induced by resveratrol and Naringenin in isolated human umbilical vein
  1115. The theory investigation for the antioxidant activity of phloretin: a comparation with Naringenin
  1116. The therapeutic potential of Naringenin: a review of clinical trials
  1117. The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin
  1118. Theoretical investigation of flavonoids Naringenin and genistein
  1119. Therapeutic efficacy of silymarin and Naringenin in reducing arsenic-induced hepatic damage in young rats
  1120. Thermodynamic modeling of Naringenin protonation equilibria in NaClO4 aqueous solutions by specific ion interaction theory and Pitzer equations
  1121. Three 2-oxoglutarate-dependent dioxygenase activities of Equisetum arvense L. forming flavone and flavonol from (2S)-Naringenin
  1122. Time courses for phytochrome-induced enzyme levels in phenylpropanoid metabolism (phenylalanine ammonia-lyase, Naringenin-chalcone synthase) compared with …
  1123. Time dependency of uterine effects of Naringenin type phytoestrogens in vivo
  1124. Tissue distribution of Naringenin conjugated metabolites following repeated dosing of naringin to rats
  1125. TNF-α blocker effect of Naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis
  1126. Topical formulation containing Naringenin: efficacy against ultraviolet B irradiation-induced skin inflammation and oxidative stress in mice
  1127. Total synthesis of three naturally occurring 6, 8-di-C-glycosylflavonoids: phloretin, Naringenin, and apigenin bis-C-β-D-glucosides
  1128. Toxicokinetics of naringin and its metabolite Naringenin after 180-day repeated oral administration in beagle dogs assayed by a rapid resolution liquid …
  1129. Trace determination of Naringenin and hesperitin by tandem mass spectrometry
  1130. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid Naringenin: role of PPARα, PPARγ and LXRα
  1131. Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and Naringenin
  1132. Treatment with Naringenin elevates the activity of transcription factor Nrf2 to protect pancreatic β-cells from streptozotocin-induced diabetes in vitro and in vivo
  1133. Trichloroethylene-mediated cytotoxicity in human epidermal keratinocytes is mediated by the rapid accumulation of intracellular calcium: Interception by Naringenin
  1134. Tumor growth attenuating effects of Naringenin
  1135. Ulcer‐protecting Effects of Naringenin on Gastric Lesions Induced by Ethanol in Rat: Role of Endogenous Prostaglandins
  1136. Understanding the structure–activity relationship between quercetin and Naringenin: in vitro
  1137. UPLC-Q-TOF-MS analysis of naringin and Naringenin and its metabolites in rat plasma after intragastrical administration of alcohol extract of exocarpium Citri grandis
  1138. UPLC-Q-TOF/MS analysis of naringin and Naringenin and its metabolites in rat urine and feces after intragastric administration of alcohol extract of Exocarpium Citri …
  1139. UPLC–MS/MS determination of paeoniflorin, naringin, Naringenin and glycyrrhetinic acid in rat plasma and its application to a pharmacokinetic study after oral …
  1140. Uterine effects of the phytoestrogen 6-(1, 1-dimethylallyl) Naringenin in rats
  1141. Validated high-performance liquid chromatographic method utilizing solid-phase extraction for the simultaneous determination of Naringenin and hesperetin in human …
  1142. Vasorelaxant effect of Naringenin and Narirutin in rat aorta
  1143. Vitamin E loaded Naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA Parkinson’s disease model
  1144. Voltammetric analysis of Naringenin at a disposable pencil graphite electrode–application to polyphenol content determination in citrus juice
  1145. Volumetric Properties, Viscosity, and Refractive Indices of Different Naringenin Solutions at Several Temperatures
  1146. β-Lactoglobulin–Naringenin complexes: Nano-vehicles for the delivery of a hydrophobic nutraceutical
Related Posts

Thymus Serpyllum

Phyllanthus Muellerianus

Vitex Cienkowskii

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping